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The field of neuroendocrinology grew immensely with the realization that steroid
hormone production is not confined to the adrenal and reproductive glands, but also
occurs in the central nervous system (CNS). Steroids synthesized de novo in the brain
and spinal cord are referred to as neurosteroid or neuroactive hormones, and
encompass estrogens, androgens, glucocorticoids, and mineralocorticoids. Though all
substrates and enzymes required for neurosteroid biosynthesis exhibit CNS expression,
a thorough comprehension of their functionality is lacking. In addition to mediating
stress responses, neurosteroids influence CNS-specific processes known to regulate
neural development and pathology. Multiple sclerosis (MS), a debilitating
neurodegenerative disorder classified by rampant demyelination, exemplifies the
neuroendocrine crosstalk facilitated by CNS-resident steroids. Local steroid production
from cholesterol, which also happens to be the primary lipid component of myelin
sheaths, is critical to myelin repair.
Progesterone in particular is implicated in expediting remyelination following
demyelinating insults in animal models via an unknown mechanism. Despite the
established effect of progesterone on myelin regeneration, its impact on early
myelinogenesis remains unclear. This observation inspired the work presented here, in
which I investigated a potential role for progesterone in embryonic oligodendrocyte
development. Applying the synthetic progestin Nestorone to mouse cerebellar slice
cultures, I found that progesterone stimulates expression of the mature myelin protein,
myelin basic protein. Curious as to whether this phenomenon mirrors progesteroneinduced remyelination at the molecular level, I implemented the same experimental
system in mice genetically altered to delete expression of the nuclear progesterone
receptor. Unexpectedly, removal of this receptor from cerebellar slices led not only to an
increase in myelin basic protein expression, but more robust oligodendrocyte maturation
into myelinating cells actively extending processes to axons and participating in fiber
formation.
The fact that this surprising effect could not be mediated by the nuclear
progesterone receptor prompted me to examine potential caveats to studying individual
hormones like progesterone in isolation. Due to the existence of multiple non-canonical
progesterone receptors expressed in the CNS, the rapid metabolism of progesterone
under physiological conditions, and endogenous astrocytic progesterone production, I
opted to transition to a mouse devoid of all neurosteroid hormones. To this end, I
obtained a transgenic strain with a mutation inhibiting activity of the enzyme that
initiates steroid hormone biosynthesis from cholesterol. Histological analyses of E18.5
embryos revealed no differences between wild-type and knockout general anatomy,
CNS architecture, or oligodendrocyte quantity and distribution in the brain and spinal

cord. I therefore concluded that access to maternal steroid hormones is sufficient to
sustain the knockout mice until inevitable perinatal lethality.
Unconvinced that the apparent histological normalcy of the knockout CNS
represented the full extent of oligodendrocyte functionality, I performed spinal cord
explant experiments in which uniform segments of spinal cords dissected from E12.5
embryos were cultured for four days with no exposure to steroid hormones. In this
protocol, fluorescent staining with oligodendrocyte transcription factor Nkx2.2 and
myelin basic protein revealed a novel CNS phenotype attributed to neurosteroid
deficiency. Diffuse Nkx2.2 and myelin basic protein staining was evident across
genotypes. However, the explants from knockout embryos also contained a significantly
elevated concentration of myelin basic protein-positive cells along the entirety of the
midline in the tissue. While further studies are necessary to determine the nature of this
abnormality, the results described here suggest excess oligodendrocyte production
and/or proliferation defects in spinal cord tissue deprived of neurosteroid hormones may
be at play. With our limited understanding of the intricacies governing oligodendrocyte
development from neural precursors, relevant neurosteroid activity undoubtedly
warrants ongoing pursuit.
Taken together, the data holds diverse implications for neurosteroid involvement
in oligodendrocyte development, distinct from the myelin repair so urgently needed in
MS patients. Spontaneous remyelination proceeds relatively normally in early acute
lesions, but progressively declines over time as lesions become chronic and prone to
glial scarring and accumulation of inflammatory cellular debris. My finding that unlike in
myelin regeneration, progesterone-induced effects on developmental myelin formation
do not rely on signaling through the nuclear progesterone receptor, reaffirms the notion
that simply recapitulating the process of early oligodendrocyte maturation is inadequate
to treat degenerative disorders like MS. The capacity of a sex hormone like
progesterone to exert such remarkable effects on oligodendrocyte behavior is in
accordance with the striking gender differences characterizing MS, which is nearly three
times more common in women but typically more severe in men. Gender-based
variations in steroid hormone levels over the course of a lifetime certainly must be
considered. Conceivably, men and women may respond uniquely to various
pharmacological interventions; thus, MS treatment modalities cannot be approached
with a “one size fits all” mentality. Future therapeutic improvements are incumbent on
accounting for the explicit sexual dimorphism of MS, to which neurosteroid hormones
assuredly contribute.

In loving memory of a biological pioneer with the purist of hearts, Dr. Bruce McEwen,
the driving force behind the inquisitive and collaborative spirit this work embodies.
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CHAPTER 1: Background and Introduction

1.1 Neurosteroid Hormones
1.1.1 Classification
The discovery of de novo steroid biosynthesis in the brain in the early 1980’s
marked a critical milestone in the advancement of neuroendocrine biology1.
Accumulating evidence such as consistent progesterone (P4) levels in castrated and
adrenalectomized rats, higher concentrations of some sterols in the central nervous
system (CNS) than in peripheral fluids, and high brain pregnenolone (Preg) levels in
newborn rats in the absence of significant adrenal sterol synthesis, all supported the
concept of the brain as an independent steroidogenic organ2-5. Such neuroactive
steroids, colloquially dubbed ‘neurosteroids,’ refer to steroids specifically generated in
the nervous system as opposed to endocrine glands, namely the gonads and adrenal
glands, or the placenta. Neurosteroid production occurs through endogenous means
and from circulating sterols in both the CNS and peripheral nervous system (PNS).
Classical CNS-derived neurosteroids include androstane- and pregnane-derived
steroids that influence neuronal excitability through neuronal plasma membrane
receptors and ion channels. Hormones such as cortisol, estrogen, and testosterone,
though neuroactive as well, are categorized as peripheral steroid hormones, and
generally signal through intracellular nuclear hormone receptors6. The vast majority of
the current literature utilizes the term ‘neurosteroid’ to encompass all steroid hormones
that induce effects within the CNS. Recent and ongoing studies continue to blur the
distinction between CNS-derived and peripheral neurosteroids, many of which are now
known to signal through nuclear as well as membrane-associated receptors7.
Baulieu’s pioneering work in the field revealed that multiple cell types in the brain
have the capacity to synthesize neurosteroids, particularly glia; astrocytes; and
hippocampal, cerebellar, and pineal neurons8-10. While free neurosteroids unbound to
albumin can transfer between the CNS and the blood via the blood-brain barrier (BBB),
their high lipophilicity typically doesn’t permit frequent secretion into the circulation11.
Instead, these neuroactive steroids tend to be confined to the membranes of the cells in
which they were synthesized, leading to predominantly local downstream effects.
Conservation of neurosteroid synthesis across mammals, birds, amphibians, and fish
indicates the essential nature of this biological process12-14. The extent of the roles for
neurosteroids in local brain signaling remains largely unknown. That being said, one
popular hypothesis maintains that neurosteroids are critical during times of low steroid
hormone levels in the circulation such as menstruation in females, and/or to increase
naturally lower levels of P4 in males15.
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1.1.2 Biosynthesis
Unlike the intricacies of the physiological relevance of neurosteroids, their
biosynthetic pathway has been studied meticulously. As mentioned above, circulating
sterols that traverse the BBB can potentially serve as precursor molecules in
neurosteroid synthesis16. However, this is not believed to be the primary mechanism.
Instead, neurosteroid synthesis typically first requires the transport of cholesterol, either
directly from the endoplasmic reticulum or from endocytosis of lipoproteins, into the
mitochondrial membrane17,18. Numerous enzymes in the cytochrome p450 family are
required for this initial step19. Further cholesterol transport from the outer to inner
mitochondrial membrane is facilitated by the formation of a complex between
steroidogenic acute regulatory protein (StAR) and translocator protein (TSPO), the latter
serving as a pore granting cholesterol access to the inner membrane18,20. The viability
of TSPO knockout (KO) mice suggests the evolution of multiple molecular methods of
cholesterol transport21. The p450 side chain cleavage enzyme (p450scc) is responsible
for catalyzing three mono-oxygenation reactions that generate Preg from cholesterol.
Technically speaking, the mere presence of p450scc is sufficient to classify a cell as
steroidogenic18. Preg is the immediate precursor to P4 and 17-hydroxypregnenolone22.
Following its passive diffusion across the outer mitochondrial membrane, enzymes with
high expression throughout the brain, namely 5α-reductase and 3α- and 5αhydroxysteroid dehydrogenase, convert P4 to various metabolites including
allopregnanolone (ALLO) and pregnanolone23. Estrogens, androgens, glucocorticoids,
and mineralocorticoids are all ultimately derived from the conversion of cholesterol to
Preg24. The fate of a particular neurosteroid hormone is dictated by expression and
activity of local enzymes, as illustrated in Figure 1.1.
The extent of extracellular mediation of neurosteroid biosynthesis is unclear at
this point. Intracellular second messengers like cyclic adenosine monophosphate and
protein kinase A stimulate 5α-reductase activity. Phosphorylation of StAR and TSPO
upregulate the import of cholesterol into the mitochondrial membrane, and has been
linked to the onset of ovulation25,26. In this prime example of tightly coordinated
peripheral and neurosteroid signaling, circulating estradiol increases P4 synthesis in
hypothalamic astrocytes. The absence of P4 in turn inhibits luteinizing hormone
secretion27.
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Figure 1.1: Neurosteroid biosynthetic pathway. All neurosteroid synthesis begins with the
conversion of cholesterol that has been transported to the outer mitochondrial membrane into Preg.
This step is required for the production of estrogens, androgens, glucocorticoids, and
mineralocorticoids. Adapted from Häggström and Richfield, 201424.

1.2 Critical roles of the neurosteroid P4 in the CNS
1.2.1 Physiological functions
P4 is widely known to work in tandem with estradiol to mediate reproductive
functions, such as uterine epithelial proliferation. However, these two hormones often
exert CNS effects independently of each other28. Whereas estradiol has been shown to
combat neuronal glutamate excitotoxicity, amyloid beta accumulation, and oxidative
stress, emerging evidence suggests distinct roles for P4 in cognition and
neuroprotection as well. P4 receptor expression identified by polymerase chain reaction
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(PCR) throughout the brain does not exhibit strict localization to specific cell types29.
The primary mechanisms by which P4 mediates CNS function include gene regulation
at the expression level, direct effects on neurotransmitters, and stimulation of various
signaling cascades. Prominent cascades involve activation of the mitogen-activated
protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) and protein kinase B
(Akt) pathways, both associated with neuronal survival, especially in the context of
ischemia30,31.
In terms of memory, preliminary studies indicate a role for P4 in synaptic
transmission and plasticity requisite for memory storage and learning. Under
physiological conditions, P4 treatment may enhance hippocampal synaptic transmission
as measured by increased field potential and population spike amplitude32. Interestingly,
while both estrogen and P4 alone promote glutamate-mediated increases in intracellular
calcium, combination treatment does not augment this effect, suggesting P4 can
actually reduce the potency of estrogen action on synaptic transmission33.
A prime example of the constant crosstalk between the nervous and endocrine
systems is the modulation of mood and cognitive function throughout different phases of
the menstrual cycle. Specifically, increased P4 levels during the luteal phase has
repeatedly been linked to overall decline in mood34,35. In conditions such as
premenstrual dysphoric disorder and postpartum depression, altered gammaaminobutyric acid (GABA) receptor sensitivity is the chief biological factor at play36. P4
influences neuronal inhibition via augmentation of chloride conductance by GABA
receptors, leading to postsynaptic membrane hyperpolarization37.
The GABAergic system is also involved in cognitive tasks such as learning,
memory accrual, face recognition, and reaction time. P4 diminishes acuity of memorybased performance in both humans and animal models38-40. Oral administration of P4 to
women presented with a barrage of faces hindered their ability to accurately recognize
the faces upon reintroduction. P4 appears to interfere with memory via the amygdala
given the decreased amygdala and fusiform gyrus activity detected by magnetic
resonance imaging39. Likewise, P4 treatment impedes the ability of rats to successfully
navigate the Morris water maze38,40. In accordance with these observations of reduced
cognitive capacity, P4 downregulates dendritic spine outgrowth to a similar extent as
ovariectomization, thereby counteracting the pro-dendritic growth capacity of estrogen41.
Signaling cascades initiated through P4 receptors found in hippocampal dendritic spines
as well as GABA inhibition through GABA receptors provide evidence for indirect and
direct P4 effects, respectively, on dendritic spine density indicative of synapse
excitation. Corresponding variations in dendritic spine quantity over the course of the
rodent estrous cycle are consistent with the suspected impact of P4 on general
cognition42.
The presence of P4 in all major glial cell types including astrocytes, microglia,
and myelinating cells of the CNS (oligodendrocytes) and PNS (Schwann cells) has been
thoroughly studied28. Astrocytic P4 modulates the production of proteins like ApoE that
transport lipids to budding neurites, and thus enable synaptic plasticity, particularly
during pregnancy upon the uterine introduction of maternal lipids43. This reserve of P4
can in turn stimulate macrophages to generate more ApoE in a cyclical manner. The
4

interplay between estrogens and P4 differs according to endocrine versus nervous
system localization44. The lack of consensus regarding the relevance of P4 activity in
isolation, especially in the CNS milieu, warrants further investigation.
Neurosteroid hormones were first identified in the PNS. Sciatic nerve Schwann
cells express the classical nuclear P4 receptor (nPR), and contain the substrates
needed to produce and metabolize P4. Several P4 derivatives, namely 5αdihydroprogesterone (DHP) and 3α,5α-tetrahydroprogesterone (THP), control the
expression of major PNS proteins glycoprotein zero (P0) via nPR and peripheral myelin
protein 22 (PMP22) via the GABAA receptor45. Sex-dependent regulation of myelin
proteins myelin-associated glycoprotein (MAG) and myelin and lymphocyte protein
(MAL) are also attributed to activity of P4 and its derivatives46. The same metabolites
were later shown to promote synthesis of CNS myelin proteins such as myelin basic
protein (MBP) and 2’,3’-cyclic nucleotide-3’-phosphodiesterase (CNPase). Although the
mechanisms by which P4 and/or its metabolites regulate CNS myelination remain
elusive, enhanced proliferation of oligodendrocyte progenitor cells (OPCs) has been
proposed15.
Indeed, P4 demonstrates positive effects on neurogenesis and neural progenitor
proliferation, among other stages of neurodevelopment (Figure 1.2). Long-term P4
administration on the order of months significantly upregulate growth factors essential to
endometrial cell proliferation in pregnant mares47. Similarly, growth factors in the brain
like brain-derived neurotrophic factor (BDNF) increase with P4 levels and decrease with
age after menopause48. The immediate P4 metabolite ALLO exhibits mitogenic behavior
on par with that of basic fibroblast growth factor (bFGF) prior to OPC proliferation and
migration49,50. Both CNS and plasma P4 stores fluctuate with menstrual cycle stage and
age, providing yet another instance of the fluidity of CNS- and endocrine gland-derived
steroid hormones48.
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Figure 1.2: Influence of P4 throughout CNS development. P4 is essential to numerous
neurodevelopmental milestones from prenatal to adult life. These events include neurogenesis,
oligodendrogenesis, myelination, neuroprotection which later combats aging and disease, brain
sexual differentiation, and maturation of neural circuits. Adapted from González-Orozco and
Camacho-Arroyo, 201951.

Ample evidence in the literature supports the stimulatory effects of P4 signaling
through nPR on OPC proliferation and morphogenesis into mature
oligodendrocytes28,52-56. In fact, oligodendroglial production of P4 is tightly correlated
with the maturation process itself. In a rather elegant model of the precisely
orchestrated autocrine and paracrine signaling mechanisms implemented by P4, OPCs
generate large quantities of P4, whereas myelinating oligodendrocytes are better
equipped for P4 metabolism57,58. Briefly, OPCs produce P4, which promotes their
vitality, thus cyclically allowing for further neurosteroid synthesis within mitochondrial
membranes. P4 pre-treatment in yeast exposed to cytotoxic reactive oxygen species
leads to mitochondrial uncoupling, a process associated with improved cellular fitness59.
Considering the expansion and inefficiency of abnormal mitochondria characteristic of
demyelinating disorders like multiple sclerosis (MS), patients may benefit from P4induced mitochondrial maintenance.
1.2.2 Implications in CNS pathology
P4 has been proposed as a neuroprotective agent in a variety of CNS disorders
including, but not limited to, epilepsy, ischemia, traumatic brain injury (TBI), Alzheimer’s
disease (AD), and MS60. The broad range of mechanisms by which P4 appears to
confer its reparative properties demonstrates its versatility as a pro-survival factor in the
brain. Experimental seizure paradigms involving kainate, pilocarpine, and
pentylenetetrazole stimulation are quite sensitive to ALLO treatment. This P4 metabolite
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simultaneously reduces the severity of seizure behaviors and attenuates neuronal injury
in the hippocampus61-64 65. By directly enhancing chloride conductance through GABAA
receptors, ALLO effectively dampens excitatory signaling, thereby preventing seizure
activity66.
Uncoupling the individual mechanisms through which P4 combats damage in the
CNS is virtually impossible due to its rapid metabolism and diverse ligand interactions.
In spinal cord injury models, for example, the hormone upregulates BDNF levels and
greatly improves mitochondrial dysfunction67,68. The anti-inflammatory effects of P4 are
especially prominent in ischemia, as is its ability to minimize oxidative stress by
reducing production of free radicals like nitric oxide in the cerebrum69. Beyond neurons,
P4-mediated signaling influences brain endothelial cells and glia, among other distinct
cell populations. Reduced BBB permeability and microglial and astrocytic activation, in
conjunction with increased myelination induced by P4, contribute to the amelioration of
ischemic and other pathological insults on the CNS70-72.
In depth studies of the restorative role of P4 in TBI confirm the benefits of both
acute and long-term P4 administration. Immediate treatment with P4 diminishes
cerebral edema, while consecutive days of P4 treatment up to one week leads to
behavioral improvements as measured by spatial learning and additional sensory
tasks73. P4 and ALLO, likely in tandem, modulate complement factors and inflammatory
cytokines following TBI. The ensuing anti-inflammatory effect is particularly prevalent in
models subjecting the medial frontal cortex to TBI74.
Gender differences in the innate capacity for recovery from TBI are striking.
Cerebral edema attributed to brain injury is significantly less pronounced in normally
cycling female as opposed to male rats, and essentially non-existent in pseudopregnant
females. Application of these studies to ovariectomized females suggests circulating P4
levels are inversely correlated with edema due to TBI75. As in many instances of CNS
pathology, ALLO exhibits restorative capabilities comparable to those of P4. Both
neurosteroids are anti-apoptotic via prevention of DNA fragmentation, inhibit lesioninduced astrocytic activation, and support retention of learning capacity and memory
typically impacted by TBI76,77. Inspired by robust in vivo support for P4 as a therapeutic
agent in brain injury, Stein et al. organized a clinical trial in comatose humans with TBI.
Though less definitive in its findings than the rodent studies, this groundbreaking trial
confirmed the possible healing properties of P4 in modern biomedical settings. This
conclusion is based on the observation that surviving participants who received P4 had
better diagnostic outcomes than those in the placebo cohort78.
AD provides yet another example of the myriad ways in which P4 participates in
pathological signaling cascades in the CNS. The widely accepted amyloid cascade
hypothesis posits that an accumulation of soluble β-amyloid inevitably leads to the
formation of insoluble clusters of aggravated β-amyloid peptides79. These fibrillar βamyloid species then initiate a series of signaling cascades ultimately resulting in
widespread neurodegeneration80-84. Gas chromatography/mass spectrometry (GC/MS)
measurements of neurosteroids in several brain regions of aged AD versus nondemented human subjects revealed a correlation between low neurosteroid and high βamyloid levels in AD patients. This trend lent credence to the hypothesis that
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neurosteroids like P4 can regulate β-amyloid metabolism in the brain85. While estrogen
has repeatedly been shown to impede β-amyloid pooling and memory loss in rodent AD
models, neurosteroids rarely act in isolation86-89. Thus, of greater clinical interest are the
synergistic effects of estrogen and P4 on AD pathology. Surprisingly, P4 seems to
counteract the healing properties of estrogen in at least one mouse model of AD90.
The benefits of P4 in demyelinating disorders like MS, unlike in AD, are wellestablished54,91-94. Myelin, the lipid-dense, oligodendrocyte-derived material ensheathing
fast-conducting axons, is among the most compositionally and metabolically intricate
structures in the vertebrate CNS95. In addition to its architectural complexity, myelin
maintains axonal health and facilitates rapid saltatory conduction. Animals with larger
brain volumes rely on CNS myelination to compensate for greater conduction
distances96. The devastating consequences of myelin damage, especially in the brain
as seen in MS, include cognitive decline, motor debilitation, and chronic pain97.
Neurosteroid hormones like P4 offer a promising avenue for repair within a
demyelinated microenvironment, i.e. an MS lesion, which becomes less permissive of
myelin regeneration over time. P4 has been implicated in several dysmyelinating mouse
phenotypes in addition to MS in humans. Notably, the brains of jimpy, shiverer, and
wobbler mutant myelin mouse strains feature elevated P4 levels, suggesting P4
contributes to myelination98. Similarly, relapsing-remitting MS (RRMS) patients generate
higher quantities of the P4 derivative, Preg, than do healthy, age-matched controls. The
correlation between elevated Preg levels and MS pathogenesis suggests an
endogenous response of the P4 synthesis pathway to CNS injury99,100. Examples of
myelin regeneration stimulated by P4 are abundant in the literature where it is clear that
P4 and synthetic derivatives like Nestorone (Nes) not only stimulate OPC migration and
maturation in multiple demyelinating rodent models, but mitigate neurological and
behavioral impediments associated with demyelination as well46,54,57,92,93,100-107. In fact,
P4 synthesized in the CNS is generated from oligodendrocyte-derived cholesterol which
comprises approximately 25% of the total myelin lipid profile92,96,108,109.
Accordingly, ample evidence supports the stimulatory effects of P4 signaling
through nPR on OPC proliferation and morphogenesis into mature
oligodendrocytes28,52-56. This pro-differentiation effect has been described
extensively53,93,102,110-112. Yet a coherent molecular mechanism connecting P4 receptors
with their respective transcriptional and downstream targets is lacking. P4 appears to
circumvent defective OPC maturation characteristic of MS lesions by upregulating prodifferentiation transcription factors including (oligodendrocyte transcription factors 1 and
2 (Olig1 and Olig2), and homeobox protein Nkx2.2 (Nkx2.2)52. Additional indirect
mechanisms likely contribute substantially to myelin regeneration according to
preliminary reports of P4-induced ERK1/2 activation and AKT phosphorylation, both of
which in turn initiate signaling cascades favoring myelin regeneration and
neuroprotection107,112-117. P4 synthesis itself may be neuroprotective, as evidenced by
negative regulation of inflammatory responses in macrophages by TSPO, an essential
actor in neurosteroidogenesis118. The profound impact of P4 on oligodendrocyte
morphology and development is indubitably sufficient to challenge, if not overcome, the
barrage of impediments to myelin regeneration within a lesioned microenvironment.
8

1.2.3 Therapeutic potential in MS
MS, the most prevalent demyelinating disease effecting neural transduction in
the CNS, manifests clinically in heterogeneous motor, sensory, and cognitive
symptoms119. Despite the widely accepted dogma that MS is an autoimmune disorder in
which one’s own immune cells attack and destroy myelin sheaths insulating axons of
the brain and spinal cord, the origins of and explanations for many of the pathological
hallmarks, namely failed myelin regeneration, remain unclear. Much like developmental
myelination, successful remyelination of damaged axons requires proliferation,
differentiation, and maturation of functional OPCs. In fact, demyelinated lesions that
emerge in early stages of MS undergo rather robust myelin regeneration despite shorter
myelin internodes that form fewer wraps than those characteristic of development. As
the disease progresses, however, myelin regeneration predictably becomes
increasingly inefficient, until it ceases entirely (Figure 1.3). Current treatment options are
largely limited to immunosuppressants with adverse side effects that do not address the
ultimate failure of myelin regeneration in a pathological context120,121. Investigators have
documented an abundance of OPCs associated with lesions, thereby refuting theories
based on OPC quantity and/or migration deficiencies122-126. An emerging relationship
between endogenous sex hormones and the regenerative capacity of the CNS
highlights the growing need to explore neurodegenerative diseases like MS from a
neuroendocrine perspective28,49,52,53,57,58,92,101-103,105,106,110,127-132.
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Figure 1.3: Myelin in physiology and disease. Developmental myelination requires proliferation,
differentiation, and maturation of OPCs, as portrayed in the top image. While this is also true of
myelin regeneration in demyelinating disorders, the disease course of MS, for example, suggests
this is not the full story. The schematic on the right conveys the typical pattern of demyelinated
lesions undergoing robust remyelination in early disease stages that progressively declines over
time133. An abundance of OPCs surrounding lesions implies OPC migration and proliferation are
normal, and the biological reasons for the differences between developmental and reparative
myelination remain a mystery in the field.

The marked effects of P4 on myelin regeneration within the lesion environment
offer compelling insight into the sexual dimorphism of MS91,132. As early as
adolescence, white matter in males contains myelin with a higher g-ratio that is
therefore thinner than white matter in females134,135. Note these data reflect a
developmental stage during which sex hormones like P4 begin to differ significantly in
concentration among males and females. While men are less susceptible to MS than
women, they experience more rapid disease progression and heightened severity136,137.
Speculative explanations for this phenomenon involve external factors such as smoking,
low sunlight exposure and circulating vitamin D levels, higher childhood body mass
index, and various contraceptive methods138.
There is indeed precedent for sexual dimorphism of myelin protein gene
expression in response to P4 and its metabolites DHP and THP in Schwann cells, the
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myelinating cells of the PNS139. The aforementioned PNS proteins PMP22 and P0 vary
in mRNA levels according to gender following treatment with P4, DHP, and THP,
supporting neurosteroid effects on myelination as early as transcription46. Preliminary
studies focused in the corpus callosum and cerebral cortex reveal that the synthetic,
high-affinity nPR agonist Nes administered to female mice following cuprizone-induced
demyelination increases the density of OPCs and mature oligodendrocytes, while
stimulating production of MBP and proteolipid protein (PLP), and decreasing astrocytic
and microglial activation93,101. Of particular interest, and depicted in Figure 1.4, is that
increased estrogen and P4 levels during pregnancy exert beneficial effects on immune
tolerance and correspond to reduced relapse rates in women with MS140-143. Based on
the observation that P4 promotes remyelination, it is appropriate that women have a
greater quantity of OPCs and turnover rate of oligodendrocytes144. High P4 levels in
females in comparison to males may then enable more efficient remyelination of
lesions.

Figure 1.4: Correlation between P4 levels and MS relapse protection during pregnancy. As a
sex hormone, P4 differs in abundance among genders and age groups within genders. Strikingly,
MS exhibits clear sexual dimorphism in terms of prevalence and disease progression for as of yet
undetermined reasons. Specifically, MS is an estimated two to five times more common in women,
but generally more severe in men. Furthermore, relapse rates in women with MS drop significantly
during pregnancy, but increase after delivery, as reflected in the graph on the left145. This trend is
coincident with a surge and subsequent plummet in P4 shown in green on the right, supporting a
correlation between P4 levels and MS symptoms.

1.3 Objectives
Emerging data highlighting the relevance of neuroendocrinology to
neurodegenerative pathology depicts CNS-derived steroid hormones as potent
regulators of disease progression and repair. A recent focus on the restorative
properties of P4 and its metabolites in the context of demyelinating conditions mirroring
those associated with MS provides a promising avenue for innovative treatment
modalities fostering myelin restoration. Crucial to understanding the molecular
mechanisms that account for P4-stimulated remyelination is determining the
physiological relationship between neurosteroid hormones and myelin development.
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Here, I describe my investigation of the contributions of endogenous neurosteroids to
early CNS development by honing in on oligodendrocytes as an ideal cell type
exhibiting a reproducibly robust response to P4 following myelin damage. Ex vivo
cerebellar and spinal cord explant cultures performed in mice lacking nPR and the
cytochrome P450 Family 11 Subfamily A Member 1 (CYP11A1) gene necessary for
neurosteroid synthesis, respectively, have helped to elucidate P4 and overall
neurosteroid functionality in early postnatal and embryonic CNS development.
Accompanied by chemical staining and immunohistochemistry of basic neural as well as
specific oligodendrocyte protein markers, these experiments reveal both the
complexities of neurosteroid signaling and its vast potential to ameliorate, if not reverse,
the biological and clinical manifestations of demyelination.
Chapter 3 explores the impact of a synthetic P4 derivative on early
oligodendrocyte development via imaging of cerebellar, myelin-related proteins in the
early neonatal mouse brain. Replicated in mice deficient in the classical nPR, these
studies highlight the many nuances of neurosteroid signaling that complicate traditional
molecular biology methods. A comprehensive review of these caveats follows.
Chapter 4 reassess the current understanding of neurosteroid functioning in the
developing CNS using a model system devoid of all endogenous neurosteroid
hormones. Late embryonic dissections of mice lacking an enzyme required for all
neurosteroid synthesis complimented by histological analyses facilitates gross,
anatomical, and molecular comparisons among the different genotypes. Follow-up
histological and immunohistochemical efforts directed towards neuron- and
oligodendrocyte-specific proteins hone in on putative roles for neurosteroid hormones
like P4 in the CNS.
Chapter 5 incorporates an ex vivo spinal cord explant procedure in the same
unique mouse strain introduced in Chapter 4 to probe the functional consequences of
severe neurosteroid deficiency on embryonic CNS development, specifically
oligodendrocyte progenitor maturation into myelinating oligodendroglial cells.
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CHAPTER 2: MATERIALS AND METHODS

2.1 bacTRAP analysis
2.1.1 P4 genes in oligodendrocytes
Gene expression in oligodendrocytes was analyzed by the bacterial artificial
chromosome translating ribosome affinity purification (bacTRAP) method as previously
described146,147. Briefly, transgenic mice expressing eGFP-tagged ribosomal protein
L10a (EGFP-L10a) in oligodendrocytes were used to affinity purify cell type specific
polysomes from cortex. Polysome-bound mRNAs or mRNAs from whole tissue were
analyzed by RNA sequencing. Evaluation of P4 receptor gene expression in
oligodendrocytes versus whole brain was based on microarray data on Olig2-bacTRAP
mice. This analysis was performed in collaboration with Dr. Eric Scmidt of the Heintz lab
at Rockefeller University.
2.2 Animals
2.2.1 Mouse strains
All animal experiments were conducted in accordance with the guidelines of the
United States National Institutes of Health Guide for the Care and Use of Laboratory
Animals, and with approval from the Institutional Animal Care and Use Committee of
Weill Cornell Medicine.
Two male mice heterozygous for the an nPR loss-of-function mutation on a
C57BL/6 background were generously provided by Dr. John Lydon of Baylor College of
Medicine in Houston, Texas. These mice were crossed with WT C57BL/6 female mice
purchased from the Jackson Laboratory to initiate breeding. In the nPR knockout
(PRKO) strain, female homozygotes, are sterile; therefore, in order to maintain the
colony, male homozygotes were continually crossed with female heterozygotes (Hets).
Wild-type (WT) littermates were used as controls in all experiments.
B6:129P-Cyp11a1tm1(GFP/cre)Pzg/J transgenic mice, cryorecovered from the
Jackson Laboratory (Stock No: 010988), contain a targeted, recombinase-expressing
mutation in the first coding exon of the endogenous Cyp11a1 locus. Mice heterozygous
for the targeted mutation are viable, fertile, normal in size, and do not display any gross
physical or behavioral abnormalities. Mice homozygous for the targeted mutation die
shortly after birth presumably due to acute dehydration and electrolyte imbalances, not
to mention their inability to convert cholesterol into Preg and produce neurosteroid
hormones. WT littermates were used as controls in all experiments.
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2.2.2 Genotyping
Genotyping of PRKO mice was performed using GoTaq® Green Master Mix
(Promega, USA, M7122) with three PCR primers in the same reaction, the sequences
of which were also provided by Dr. Lydon’s lab. Primers 5’-CTT CAC CCA CCG GTA
CCT TAC GCT TC-3’ (L1) and 5’-GTG AGC ACT CCC CGA GGT A-3’ (PZ4) identified
the 140-base pair amplicon corresponding to the PRKO mutation allele. Primers 5’-CGG
AGA AGG ACA GCA GAC TC-3’ (PZ1) and PZ4 identified the 302-base pair amplicon
corresponding to the WT P4 receptor allele. DNA for genotyping was isolated using the
DNeasy Blood & Tissue Kit (Qiagen, Germany, 69506) from tail tissue. PCR results
were visualized by gel electrophoresis on 1% agarose gels with ethidium bromide. PCR
conditions are shown in Table 2.1.
Table 2.1: PCR conditions for genotyping of PRKO mice.

Step
Initial heat activation
Denaturing
Annealing
Extension
Cycles
Final extension
Hold

Temperature (°C)
95
94
56
72
Go to Step 2
72
4

Time
5 min
50 s
50 s
50 s
30 times
5 min
Forever

Genotyping of B6:129P-Cyp11a1tm1(GFP/cre)Pzg/J transgenic mice was performed
using GoTaq® Green Master Mix (Promega, USA, M7122) with three PCR primers in
the same reaction. Primers 5’-GAG CTG CCT GCC AGT GTT TG-3’ (Common) and 5’GGA CCT AGG ACT GCT AGT AG-3’ (WT) identified the 368-base pair amplicon
corresponding to the WT allele, while the primers 5’-GTC CAG CTC GAC CAG GAT
GG-3’ (Mut) and Common identified the 296-base pair amplicon corresponding to the
mutant allele. DNA for genotyping embryos was isolated using a rapid mouse tail DNA
extraction kit (Thermo Fisher Scientific, USA, 101 BIO T605). PCR results were
visualized by gel electrophoresis on 2% agarose gels with ethidium bromide. PCR
conditions are shown in Table 2.2.
Table 2.2: PCR conditions for genotyping Cyp11a1 mice.

Step
Initial heat activation
Denaturing
Annealing
Extension
Cycles
Final extension
Hold

Temperature (°C)
95
94
60
72
Go to Step 2
72
4
14

Time
2 min
30 s
30 s
30 s
30 times
5 min
Forever

2.3 Ex vivo cerebellar slice culture
2.3.1 Cerebellar slice culture procedure
Organotypic cerebellar slice cultures were prepared according to established
protocols by Stoppini et al. (1991) using brain tissue isolated from postnatal day 7 (P7)
C57BL/6 mice148. Following decapitation, mice cerebella were removed from the skull
and separated from the hindbrain in modified Eagle medium (MEM: Gibco, USA,
11090081) on ice, and cut into 350-μm parasagittal slices using the McIlwain tissue
chopper (Ted Pella, Inc., USA, 10810). Slices were separated with fine forceps under a
dissection microscope. Three slices were grown on each 30 mm Millicell cell culture
insert (MilliporeSigma, USA, PICMORG50) in 1 mL of culture media comprised of 50%
basal medium with Earle’s salts (Gibco, USA, 21010046), 25% Hanks’ buffered salt
solution (Invitrogen, USA, 14025050), and 25% Gibco heat-inactivated horse serum
(Thermo Fisher Scientific, USA, 26050088), supplemented with 5 mg/ml Gibco glucose
(Thermo Fisher Scientific, USA, A2494001), 1% Gibco Penicillin-Streptomycin (Thermo
Fisher Scientific, USA, 15140122), and 1% Gibco GlutaMAX Supplement (Thermo
Fisher Scientific, USA, 35050061). Slices were given two weeks in culture to myelinate
with complete media changes every other day.
2.3.2 Nes treatment of cerebellar slices
Cerebellar slices were prepared as described above. Slices were left to acclimate
to culture conditions for two days post-dissection, at which point they were treated with
either 20 or 50 μM Nes (MilliporeSigma, USA, SML0550) dissolved in dimethyl sulfoxide
(DMSO). Vehicle controls were treated with corresponding concentrations of DMSO.
Nes and DMSO were added to fresh media just prior to daily half media changes. Slices
were fixed at seven and 14 days post-dissection in 4% paraformaldehyde (PFA).
2.3.3 Staining of cerebellar slices
After fixation, cerebellar slices were gently cut out of the inserts. The slices were
then permeabilized with 0.5% Triton X-100, followed by blocking in phosphate buffered
saline (PBS) containing 10% normal serum for two to four hours at room temperature
(RT). The slices were then incubated with a primary anti-MBP monoclonal antibody
(Santa Cruz Biotechnology, USA, sc-271524) diluted 1:200 in PBS buffer containing
0.2% Triton X-100. The slices were washed three times and then incubated with the
appropriate FITC-conjugated secondary antibody diluted 1:500 in the same buffer.
These steps were all performed overnight at 4ºC. Finally, the sections were mounted in
4’,6-diamidino-2-phenylindole (DAPI) containing Vectashield mounting medium (Vector
Laboratories, USA, H-1200-10).
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2.3.4 Imaging and quantitative analysis
Cerebellar slices were imaged on the Nikon Eclipse 90i Motorized Upright
Microscope. All images were taken at the same shutter setting. Green fluorescent
protein (GFP) fluorescence intensity was quantified on the ImageJ software, with all raw
images adjusted to the same brightness level. Fluorescence intensity measurements
were based on lower magnification (10x) images of the cerebellar slices in their entirety;
higher magnification images were used for qualitative analysis only.
2.4 Ex vivo spinal cord explant culture
2.4.1 Preparation of charcoal-stripped mouse serum
Mouse serum used in spinal cord explant media was subject to charcoal
stripping, a process during which prolonged exposure to dextran-coated, activated
charcoal facilitates removal of steroid hormones, according to manufacturer’s
instructions. Briefly, dextran-coated charcoal (DCC) was prepared by incubating Norit A
charcoal (MilliporeSigma, USA, C3345) and dextran T-70 (MilliporeSigma, USA, D1390)
in 0.25 M sucrose, 1.5 mM MgCl2, and 10 mM HEPES pH 7.4 at final concentrations of
0.25% and 0.0025%, respectively. A volume of the DCC equivalent to that of the serum
to be stripped was centrifuged at 500 g for 10 min to pellet the charcoal. The
supernatant was decanted and replaced with the same volume of low endotoxin
deionized water. The resuspended pellet was then subject to an additional 500 g, 10minute centrifugation. The washed charcoal pellet was resuspended in the same
volume of normal mouse serum (Thermo Fisher Scientific, USA, 10410) for an
equivalent of 253 mg DCC per 100 mL normal mouse serum. The mixture was
thoroughly mixed by vortexing, and incubated for 12 hours at 4ºC. The stripped serum
was then passed through a filter series consisting of a pre-filter, 0.45-µM filter, and 0.2µm filter, and stored at -20 ºC until use. Charcoal stripping was performed by members
in the lab of Dr. Narender Kumar of the Population Council at Rockefeller University.
2.4.2 Spinal cord explant procedure
Litters were obtained from timed pregnancies of B6;129PCyp11a1tm1(GFP/cre)Pzg/J+/- female and B6;129P-Cyp11a1tm1(GFP/cre)Pzg/J+/- male matings,
and embryos were harvested at embryonic day (E)12.5. The day of vaginal plug
identification was considered E0.5. Each embryo was assigned a code number for
retrograde genotyping via PCR analysis on remaining tissue. Spinal cords were
dissected and cut transversely into one- to two-mm fragments for explant culture onto
0.4 µm Millicell cell culture inserts (MilliporeSigma, USA, PICM03050) placed in sterile,
flat-bottom, tissue-culture treated six-well cell culture plates (Corning, USA, 3516).
Explants were cultured in hormone-free media comprised of DMEM without phenol red
(Thermo Fisher Scientific, USA, 21041025), ITS (Thermo Fisher Scientific, USA,
41400045), 2% charcoal-stripped normal mouse serum, and 10 ng/mL PDGF-AA
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(PeproTech, USA, 100-13A). This particular media composition was adapted from
Vartanian et al., with ITS replacing P4-containing N2 supplement149. Half media
changes were performed daily to maintain the tissue in culture.
2.4.3 Staining of spinal cord explants
Explants were fixed on hypothetical E17.5 in 4% PFA, 5% sucrose for 20 min at
RT. After fixation, explants were gently cut out of the insert. They were then
permeabilized with 0.5% Triton X-100, followed by blocking in PBS buffer containing
10% normal serum for two to four hours at RT. Blocked slices were incubated with a
primary anti-MBP monoclonal antibody (Santa Cruz Biotechnology, USA, sc-271524) or
polyclonal anti-Nkx2.2 antibody (Thermo Fisher Scientific, USA, PA5-78079) diluted
1:200 in PBS buffer containing 0.2% Triton X-100. The slices were washed three times
and incubated with the appropriate FITC- (MBP) or Cy3- (Nkx2.2) conjugated secondary
antibody diluted 1:500 in the same buffer. These steps were all performed overnight at
4ºC. Finally, the sections were mounted in DAPI-containing Vectashield.
2.4.4 Imaging and quantitative analysis
Fixed and stained spinal cord explants were imaged on the CaliberID ribbon
scanning confocal microscope (Caliber Imaging & Diagnostics, Inc., USA) at the
Rockefeller University Bio-Imaging Resource Center. Samples were imaged with a
20x/0.8 UplanXApo lens (Olympus,USA), using laser lines of 450 nm, 488 nm, 561 nm,
and 640 nm for excitation in the four different channels.
Maximum intensity Z-stack projections of the raw images from both green (MBP)
and red (Nkx2.2) channels were generated in Imaris image analysis software, version
9.8.2. To measure the dispersal of cells away from the midline of the explants,
fluorescence intensity measurements were made along a series of five parallel lines
drawn perpendicular to the midline using Fiji. Briefly, five lines of equal length (1,176
µm) and width (100 µm) were drawn perpendicular to the midline across the length of
each explant. Identical sets of lines were applied to the individual explants for the
maximum intensity projection images corresponding to both the green and red
channels. The fluorescence intensity was measured at regular intervals along the five
parallel lines and listed as a set of (x,y) coordinates, with the x coordinate reflecting
distance along the line in µm, and the y coordinate reflecting the mean fluorescence
intensity at that particular location. These values were saved as an Excel file. A custom
R script was written in RStudio to read the Excel file, calculate average fluorescence
intensity for all five lines at each point along the line, and plot them as ±SEM. The script
was run separately for the MBP and Nkx2.2 channels for each explant. The final line
plots depict the fluorescence intensity profiles across the length of the explant, with the
solid line representing the mean intensity through the entire Z-stack, and the shaded
regions representing the standard error of the mean. Christina Pyrgaki of the BioImaging Resource Center (RRID: SCR_017791) helped with the imaging of the spinal
cord explants on the ribbon scanning confocal microscope. Ved Sharma, also from the
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Bio-Imaging Resource Center, helped with the quantitative analysis of the explant
fluorescence intensity measurements and wrote the R script for the line profile
generation.
2.5 Immunohistochemistry on B6:129P-Cyp11a1tm1(GFP/cre)Pzg/J embryos
2.5.1 Embryo collection and fixation
Litters were obtained from breeding pairs of B6;129P-Cyp11a1tm1(GFP/cre)Pzg/J+/females and B6;129P-Cyp11a1tm1(GFP/cre)Pzg/J+/- males with a 12-hour mating window
overnight from 6:00 PM to 6:00 AM. Embryos were harvested at E18.5. The day of
vaginal plug identification was designated E0.5.
Each embryo was assigned a code number for retrograde genotyping via PCR
analysis on limb tissue. Embryos and corresponding placentae were carefully dissected
and weighed. After decapitation using scissors, embryo bodies and heads as well as
placentae were fixed in modified Davidson’s fixative (Fisher Scientific, USA, 50-292-28)
containing 14% denatured ethyl alcohol, 37.5% formalin, and 37-39% glacial acetic acid
in deionized water for 48 hours at 4ºC in 50 mL conical tubes to achieve a 10:1 ratio of
fixative volume to tissue volume. This fixative was selected based on its optimization for
fixation of testis with a capsule similar in thickness to the skin of the E18.5 mouse
embryos. Unlike the traditionally used Bouin’s fluid (5% acetic acid, 9% formaldehyde,
0.9% picric acid), modified Davidson’s fixative is not regulated as a hazardous material,
does not spontaneously explode with prolonged storage, and minimizes tissue
shrinkage during the fixation process150. The tissues were then transferred to new 50
mL conical tubes containing 70% ethanol and shipped to Elizabeth Chlipala of Premier
Laboratory in Longmont, Colorado for histological processing.
2.5.2 Histology
For the placenta, one section through the midline of the organ was prepared for
hematoxylin and eosin (H&E) staining to assess general architecture.
For each embryo, the head/brain was processed whole to paraffin, after which 5µm-thick sections were collected at the locations designated 2, 3, 4, and 5 in Figure 2.1,
along with hippocampus. The resultant five to eight levels per head/brain per animal
were stained with H&E (to demonstrate general organ [brain] architecture) or cresyl
violet (to assess specific neuronal populations), or labeled by indirect
immunohistochemistry (IHC) to identify the proteins cleaved caspase-3 (for apoptotic
cells), class III beta-tubulin (TUJ1, to demonstrate early differentiation stages of
neurons), Olig2 (to reveal myelin-producing cells in the CNS), or MBP (to show myelin).
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Figure 2.1: E18.5 brain sectioning strategy. Transverse (coronal) brain sections were taken as
numerically indicated on the left to produce corresponding tissue sections with region-specific
anatomical features shown on the right151. Brain is present in levels two through
six.

Sagittal slices through the body of each embryo were taken at multiple intervals
spaced 100-200 µm apart, resulting in up to ten levels per embryo. The trimming planes
were oriented using the umbilicus and tail as external landmarks to ensure that the
spinal cord and adrenal gland would be available for evaluation. All levels were stained
with H&E, and one spinal cord-containing level was stained for TUJ1, Olig2, and MBP.
Transverse spinal cord sections were taken to assess TUJ1, Olig2, and MBP staining.
The body of the embryo was grossed into three transverse sections, with the initial
sections captured at the last rib, embedded caudal side down. After dividing the
remaining portion of the body in half, the middle section was embedded caudal side
down, and the lower portion rostral side down. Three levels were collected at 100-µm
depths and stained for H&E. One section per body was stained with TUJ1, Olig2, and
MBP.

Figure 2.2: E18.5 torso sectioning strategy. Sagittal sections were taken through the torso as
numerically indicated for H&E staining151. The face denoted by the asterisks was placed down in the
cassette. Sectioning through the left part of the torso was done to ensure that structures located only
on the left side (e.g. spleen, stomach) would be present for examination.

Samples for IHC were sectioned at 5 µm and mounted onto charged slides.
Slides were dried overnight, baked at 60°C for one hour, deparaffinized in xylene, rinsed
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in alcohol, rehydrated in water, and equilibrated in wash buffer (Tris buffered saline with
0.05% Tween 20; Dako, K8007). Heat-induced epitope retrieval (HIER) was performed
in a Dako PT Link using a 20-minute 95°C program. Tris/EDTA HIER buffer (Dako,
#K8004) was used prior to cleaved caspase-3 staining, and Citrate HIER buffer (Agilent,
K8005) was used prior to Olig2 and TUJ1. Slides were then cooled and rinsed in wash
buffer and the remaining IHC steps were carried out at RT on an Autostainer PlusLink
stainer (Dako). Proteolytic-induced epitope retrieval (PIER) using Proteinase K for two
minutes (Dako, #S3020) was performed prior to MBP staining. Within the autostainer,
serum-free protein block was applied for five minutes (Dako, #X0909).
The following primary antibodies and concentrations were used: rabbit
polyclonal-anti beta III tubulin primary antibody (0.16 µg/mL, Sigma, #T2200); rabbit
monoclonal [5A1E] anti-cleaved caspase-3 primary antibody (0.27 µg/mL, Cell
Signaling, #9664); rabbit polyclonal anti-Olig2 primary antibody (0.67 µg/mL, Millipore
#AB9610); and rabbit polyclonal anti-MBP primary antibody (14 µg/mL, Agilent #A0623).
All primary antibodies were incubated for 30 minutes at RT. Primary antibodies were
detected using EnVision+ anti-Rabbit Labelled Polymer-HRP for 30 minutes (Dako,
K4003) and DAB+ Chromogen Solution for five minutes (Dako, K3468). Wash buffer
rinses were applied between appropriate reagents. Slides were then manually rinsed in
tap water and counterstained for five minutes in a modified Harris hematoxylin (Dako,
S3301). The slides were again rinsed in tap water, and wash buffer was used as the
hematoxylin bluing reagent. The slides were then dehydrated in absolute alcohol
solutions, cleared in xylene, and cover-slipped.
Formalin pigment was observed in some of the samples part way through
completing IHC staining. A formalin pigment removal procedure was utilized for slides
that were stained for Olig2 and MBP. After IHC staining, prior to counterstaining in
hematoxylin, formalin pigment was removed by incubating slides in 70% alcoholic
ammonium hydroxide for 30 min. Mark Butters of Premier Laboratory performed the
IHC.
2.5.3 Imaging and analysis
All stained slides were scanned at 20x on an Aperio ScanScope AT2. For
microscopic evaluation, cell and tissue features were assessed using a conventional
bright-field transmitted light microscope (Nikon Eclipse E600) to define potential tissue
and cell differences between mutant embryos and WT controls. The assessment was
performed by Brad Bolon, an American College of Veterinary Pathologists boardcertified experimental pathologist with considerable experience in anatomic analysis of
developing mouse embryos and placentae.
The microscopic examination was performed in two stages. The initial phase
identified differences and assigned semi-quantitative grades using a tiered scale: within
normal limits (grade 0), minimal (grade 1), mild (grade 2), moderate (grade 3), or
marked (grade 4) changes. These grades were assigned using an informed approach
(i.e., with foreknowledge of the animal genotype). For the second phase, sections of
possible target tissues (based on apparent genotype-related differences) were re20

evaluated using a coded (blinded) approach whereby tissues were sorted into groups
based on grading criteria developed during the informed analysis. For the study, this
phase 2 assessment was performed on the adrenal gland and selected brain sections
(specifically those with hypothalamus and pituitary gland [approximately equivalent to
level 4 of Figure 2.1)].
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CHAPTER 3: Role of P4 in Oligodendrocyte Development

3.1 Confirmation of P4 effects on myelination
3.1.1 Nes is an optimal experimental P4 substitute
Given the abundance of data supporting a role for P4 in remyelination, we sought
to determine whether this particular neurosteroid exhibits similar effects during
developmental myelination. In terms of experimental P4 treatment, we chose to utilize a
synthetic P4 derivative referred to as Nes. While many progestins like Nes are
commercially available, they all differ in structure, neurosteroid receptor binding profiles,
and biological activity. Nes was deemed the optimal progestin due to its greater impact
on myelin repair, as well as higher affinity and specificity for the classical intracellular
nPR than P4 itself. As evident in the seven progestins listed in Table 3.1, the binding
affinity of Nes to the nuclear glucocorticoid receptor is weaker than that of P4, and is
virtually non-existent to the nuclear androgen receptor152. These relative binding profiles
suggest that Nes is an ideal progestin in terms of ensuring biological activity mediated
through nPR. On a similar note, Nes, unlike P4, only undergoes minimal metabolism to
3a- and 5a-tetrahydronestorone. These intermediates have a limited capacity to
activate GABA type receptors as the abundant P4 metabolite ALLO does153. The
physiological conversion of P4 to ALLO occurs within a matter of minutes, thereby
complicating the isolation of endogenous P4 in experimental paradigms. Importantly,
Nes induces the same neuroprotective and anti-inflammatory effects attributed to P4, as
demonstrated in a stroke disease model in mice in which a 0.08 mg/kg dose of Nes
intraperitoneally most significantly stimulated neuronal repair56. My cerebellar slice
culture experiments described below were designed based on this dosage.
Table 3.1: Progestogen binding to nuclear steroid hormone receptors.

Progestogen
Progesterone
MPA
Nestorone
NET
NETA
Norethynodrel
LNG
NGM

nPR IC50 (nM)
9.01
6.2
5.07
14.32
38.92
67.76
5.46
482.8

AR IC50 (nM)
119.3
4.53
No binding
18.02
876.9
196.7
2.9
5.02

GR IC50 (nM)
6.51
1.42
8.71
97.84
202.7
1306
16.73
287.1

3.1.2 Nes enhances MBP expression in cerebellar slices
Due to the paucity of data on the necessity for neurosteroid hormones in neural
development, I evaluated the effect of Nes administration to mouse cerebellar slice
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cultures on MBP expression during the time period when physiological myelination
occurs106,154. Briefly, cerebella were dissected from P7 mouse pups, chopped into 350μm thick slices, and cultured on nylon membrane inserts placed in six-well plates. After
24 hours of acclimating to the culture media, slices were treated with 20 μM or 50 μM
Nes, or DMSO vehicle control, for seven or 14 days (Figure 3.1) The nylon membranes
were cut out and transferred to 24-well plates for permeabilization in 0.5% Triton-X-100
and blocking in 5% donkey serum. Permeabilized slices were stained with a mouse antiMBP antibody at 1:100 overnight at 4ºC, followed by an anti-mouse secondary antibody
at 1:200 overnight at 4ºC. The nylon membranes were mounted on slides and visualized
under a fluorescent microscope.

Figure 3.1: Cerebellar slice paradigm to evaluate Nes effects on myelination. 350-micron thick
mouse cerebellar slices were dissected from P7 mouse pups and cultured on nylon membrane well
inserts placed in six-well plates. Each well contained two to three slices. After Nes or vehicle
treatment, the slices were fixed in 4% PFA in the same six-well plates. The nylon membranes were
cut out and transferred to 24-well plates for permeabilization in 0.5% Triton-X-100 and blocking in
5% donkey serum. Slices were then stained with a mouse MBP antibody at a concentration of 1:100
overnight at 4ºC followed by an anti-mouse secondary at 1:200 overnight at 4ºC. The nylon
membranes were mounted on slides and visualized under a fluorescent microscope.

Nes treatment significantly enhanced myelination as assessed by fluorescent
staining intensity of the mature myelin protein, MBP. Representative images from each
condition (Fig. 3.2) indicate enhanced MBP expression in Nes-treated as opposed to
control-treated slices in nearly all conditions. Quantitative analyses (Fig. 3.2) confirm
this trend, with the exception of the 14-day, 50 μM Nes treatment. The most striking
effects were seen at the seven-day timepoint, with 20 and 50 μM Nes treatment
resulting in 96% and 81% increases in MBP fluorescence intensity, respectively,
compared to that in vehicle-treated control slices. This trend was more modest at the
14-day timepoint, with 20 uM Nes treatment leading to a 35% increase in MBP
fluorescence intensity. Interestingly, no effect was apparent with 50 uM treatment. This
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data suggests P4 is involved in, but not necessarily required for, myelination at an early
postnatal age. While my expectation is that the neurosteroid is in fact essential to
developmental myelination, such a finding would be novel.
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Figure 3.2: Nes-induced MBP expression in developing mouse cerebellar explants. 350-uM
thick cerebellar slices were dissected from P7 mouse pups and plated in media containing 20 uM
Nes, 50 uM Nes, or DMSO vehicle control for seven or 14 days, and fluorescently stained for DAPI
(blue) and MBP (green). Nes stimulated MBP expression at D7 and D14, with the exception of the
50 uM concentration at D14. Quantitative analysis reveals statistically significant increases in MBP
expression at D7 with 20 uM and 50 uM Nes treatment compared to DMSO controls, as well as
between 20 uM Nes treatment at D7 versus D14. Results expressed as Mean ± STDEV, p < 0.05 =
*, p < 0.01 = **, p < 0.001 = *** determined by two-way ANOVA, n = 6 cerebellar slices per condition.
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3.1.3 Discussion
The significant increase in MBP expression following one week of treatment with
Nes corroborated the little data that is currently available regarding the role of P4 in
murine embryonic myelin development106,154. However, the reason for the more modest
trend in Nes-induced enhancement in MBP expression at the Day 14 timepoint (Figure
3.2) is not yet clear. Presumably, the explanation for this phenomenon depends on the
mechanism by which P4 is leading to an increase in MBP-positive cells during early
myelination. It is possible that Nes specifically promotes a stage of OPC maturation that
has already terminated by the third week of life, corresponding to D14 in the
experimental paradigm described here. For instance, the majority of OPCs have already
undergone successful differentiation by the peak of myelination which occurs prior to
the three weeks post-birth mark155. Therefore, if P4 does in fact stimulate OPC
differentiation, we would expect the effect of Nes on MBP expression to steadily decline
as this fluid process approaches completion.
On a similar note, there is not a distinct difference between MBP expression
following administration of 50 uM Nes between D7 and D14 (Figure 3.2). This
stagnancy in MBP fluorescence intensity suggests an external factor at play such as
oligodendrocyte cell death and/or a threshold of Nes benefits at or near the 50 uM
concentration. Consistent with this hypothesis, it is known that CNS development does
involve substantial apoptosis of excess OPCs that are not destined to differentiate into
myelinating oligodendrocytes. Of note, oligodendrocyte quantities and myelination
levels remain relatively constant, even upon introduction of endogenous OPCs into the
system156. Apoptosis thus seems to be an inevitable aspect of myelin tract formation
within the CNS.
Though these preliminary data certainly imply a role for P4 in developmental
myelination, inherent limitations of the experimental design warrant further investigation
of both the extent to which P4 is required during this window of time, as well as the
mechanism of P4-mediated MBP enrichment proposed in the literature and confirmed in
these studies. Paramount among these limitations is the lack of mechanistic insight into
how the presence of P4 leads to MBP expression in the early postnatal cerebellum.
Direct action on OPC differentiation is merely one example of the varied ways in which
P4 activity might impact myelin development. Others include effects on OPC
proliferation and/or migration, potentially accounted for by a number of candidate
signaling cascades associated with neurosteroid hormones. Due to the specificity of
Nes for nPR, we conducted follow-up loss of function studies in mice lacking this
nuclear receptor. The two manuscripts to date that address Nes effects on
developmental myelination rely on cerebellar slice cultures from a mouse strain with a
germline loss-of-function mutation at the nPR locus106,154. At the time, Dr. John Lydon of
Baylor University was the only investigator actively breeding these PRKO mice, and
generously offered to contribute animals to my endeavors. He discontinued this line
shortly after sending me one male WT and two male Hets. The PRKO mice were
successfully acquired from Baylor and quarantined, and ultimately crossed with WT
C57BL/6J females from The Jackson Laboratory to produce a full colony.
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3.2 Inhibition of nPR during myelination
3.2.1 Establishment of PRKO transgenic mouse line
PRKO mice were created by the insertion of a neomycin resistance gene into
exon 1, thereby preventing nPR transcription and inhibiting functional mRNA expression
for both nPR isoforms A and B (Figure 3.3)157. Members of Dr. Lydon’s lab provided
primer sequences and a specific PCR protocol for genotyping. The inclusion of three
primers yielded a 302-bp amplicon corresponding to the WT nPR allele and a 140-bp
amplicon corresponding to the mutant PRKO allele (Figure 3.4). I was able to produce
male and female Hets and homozygous KOs. Importantly, homozygous females are
sterile, meaning I couldn’t generate an entirely homozygous colony for experimental
purposes. In the following cerebellar slice experiments, pups were genotyped on P1 or
P2 in order to identify the KOs prior to P7 when cerebella are dissected in the slice
culture procedure. Homozygous males were continuously bred with heterozygous
females to maintain the colony and support related experiments.

Figure 3.3: Genetic construct of PRKO mice. The targeting vector RV7, used for the positivenegative selection, is shown at the top. The solid boxes represent exon 1 and exon 2. The open
boxes that are located 3' to exon 1 and 2 are intronic sequences, whereas the open box 5' to exon 1
represents the 5'-untranslated region. The neo r and the HSV-TK gene are indicated, with arrows
showing the direction of transcription. The vector sequence pSP72 is located at the 5' end of RV7.
The relevant restriction sites are indicated. After homologous recombination between RV7 and the
mPR genomic locus, the predicted structure of the mutated nPR allele is depicted at the bottom. The
expected sizes of the various restriction fragments, detected by the 5' and 3' probes, are shown for
both the intact and targeted disrupted locus. The 5' and 3' probe fragments are indicated by solid
boxes157

26

Figure 3.4: Genotyping of PRKO mice. Three primers were combined in the same PCR reaction to
generate a 140-bp amplicon corresponding to the PRKO mutation allele and a 302-bp amplicon for
the WT allele. Presence of both amplicons indicates a Het.

3.2.2 nPR-mediated effects on myelination
My initial aim was to confirm P4-mediated amplification of MBP staining as
suggested in the literature106. I employed the same techniques implemented in the
previous experiment, in which cerebella were dissected from P7 mouse pups, chopped
into 350-μm thick slices, and cultured on nylon membrane inserts placed in six-well
plates. The key variable in this experimental paradigm was the mouse genotype.
Whereas before I strictly used WT mice to confirm a P4 effect on myelin development in
general, I now sought to determine the extent to which nPR regulates myelin
development in the PRKO mouse strain. Slices were treated after 24 hours as before
with only 20 μM Nes (which was shown to be more effective than the 50 μM
concentration, Figure 3.2), or DMSO vehicle control, for seven days (Figure 3.5) The
nylon membranes were excised and transferred to 24-well plates for permeabilization in
0.5% Triton-X-100 and blocking in 5% donkey serum. Permeabilized slices were stained
with a mouse anti-MBP antibody at 1:100 overnight at 4ºC, followed by an anti-mouse
secondary antibody at 1:200 overnight at 4ºC. The nylon membranes were mounted on
slides and visualized under a fluorescent microscope.
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Figure 3.5: Cerebellar slice paradigm to evaluate Nes effects on myelination in PRKO mice.
350-micron thick mouse cerebellar slices were dissected from P7 mouse pups and cultured on nylon
membrane well inserts placed in six-well plates. Each well contained two to three slices. After Nes or
vehicle treatment, the slices were fixed in 4% PFA in the same six-well plates. The nylon
membranes were cut out and transferred to 24-well plates for permeabilization in 0.5% Triton-X-100
and blocking in 5% donkey serum. Slices were then stained with a mouse MBP antibody at a
concentration of 1:100 overnight at 4ºC followed by an anti-mouse secondary at 1:200 overnight at
4ºC. The nylon membranes were mounted on slides and visualized under a fluorescent microscope.

As expected, only scarce differences were present between untreated and
DMSO controls across both nPR+/- (Het) and nPR-/- (KO) genotypes. Nes treatment did
increase MBP expression as compared to the DMSO vehicle control conditions in Hets
and KOs by 12.87% and 74.89%, respectively. However, Nes-induced MBP expression
was surprisingly 67.3% greater in the KOs than the Hets. In addition to the enhanced
fluorescence intensity seen in slices from the nPR-/- mice, the MBP-outlined myelin
tracts in this genotype are visibly denser with a much greater extent of branched
processes. The majority of the MBP positivity in the KO tissue can be attributed to
actively myelinating oligodendrocytes. Most of the MBP-positive cells in the Het tissue,
on the other hand, exist in isolation without any evidence of participating in myelination
(Figure 3.6). Contradictory to the established notion that P4 stimulates myelin repair in
the context of neurodegenerative disease by signaling through nPR, these findings
suggest that the mechanism is not as straightforward in developmental
myelination46,53,54,57,92,93,100,101,103-107.
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Figure 3.6: Nes-induced MBP expression in developing cerebellar explants from PRKO mice.
350-uM thick cerebellar slices were dissected from P7 nPR+/- and nPR-/- mouse pups and plated in
media containing 20 uM Nes or DMSO vehicle control for seven days, and fluorescently stained for
MBP (green). Nes stimulated MBP expression in both phenotypes, although to a greater extent in
nPR-/- mice (A). Prominent myelin tracts with numerous processes are visible in the nPR-/- mice as
well (B). Quantitative analysis reveals statistically significant increases in Nes-induced MBP
expression in the nPR-/- as compared to the nPR+/- mice (C). Results expressed as Mean ± STDEV,
p < 0.05 = *, p < 0.01 = **, p < 0.001 = *** determined by two-way ANOVA with Tukey’s honestly
significant difference post-hoc testing, n = 6 cerebellar slices per condition.

30

3.2.3 Discussion
The expedited myelin development in the PRKO mice as compared to the Hets
was rather surprising. Not only did Nes increase MBP fluorescence intensity in the KOs,
but distinctly altered myelin architecture as well. The enlarged images in Figure 3.6, B
show small clusters of MBP-positive cells dispersed throughout the Het cerebellum
adjacent to several myelinated tracts (left), as opposed to abundant processes
extending from a dense bundle of overlapping myelin tracts illuminating the PRKO
cerebellum (right). We would have expected a drastic decrease in MBP expression in
the PRKO mice under the assumption that Nes is signaling through nPR to impact
myelin development. The data, however, challenge this hypothesis, as the PRKO mice
feature a more robust and mature myelin phenotype than their Het counterparts in
response to 20 uM Nes.
One plausible scenario involves compensatory action by redundant pathways
initiated by P4, or Nes in this case. Myelination is such a vital neurological process that
it is reasonable to suspect multiple pathways have evolved to ensure that it proceeds
normally. Perhaps Nes has the capacity to activate other receptors in the absence of
nPR that in turn upregulate MBP expression during myelin development. Alternatively,
P4 signaling through nPR could exert dual effects on myelination. For example, it is
conceivable that P4 could inhibit OPC maturation and differentiation, but stimulate OPC
proliferation. This explanation is compatible with the MBP-positive cell clusters without
extensive myelination seen in the Hets in the presence of nPR, contrasted with the
heavily myelinated tracts seen in the PRKO mice lacking nPR.
Gender is another factor that was not accounted for here but must be taken into
consideration for analytical purposes. Males and females are known to differ drastically
in quantities of hormones like P4, as well as overall myelin content and structure158.
Cerghet et al. implemented immunocytochemistry and in situ hybridization to
demonstrate that oligodendrocyte density is 20-40% greater in the young and adult
male versus female corpus callosum, fornix, and spinal cord. MBP expression, the
quantitative metric used in my cerebellar slice paradigm, can be up to 160% greater in
the male brain as assessed by Western blot. Interestingly, oligodendrocyte and
therefore myelin turnover is much more rapid in the female rodent brain, with rampant
glial generation and apoptosis159. The consequences of such sexually dimorphic
oligodendrocyte content and lifespan in the CNS are not fully comprehended.
Because the pups used in these experiments were not segregated by sex, we
cannot rule out a potential role for gender in the novel data. On one hand, the heavily
myelinated and branched tracts featured in the KO cerebella may be attributed to a
greater number of females assigned to that cohort, with correspondingly higher levels of
P4. Regardless of sex, P4 in the KOs must still be acting, at minimum, through a nonnPR-mediated pathway. On the other hand, or perhaps in parallel, P4 may activate
different signaling pathways according to sex. Still, the logical conclusion remains that
the molecular mechanism of P4-induced myelination phenotypes extends beyond the
traditional nPR.

31

Based on the sheer complexity of P4 signaling, additional receptors are likely
responsive to Nes. González-Orozco et al. maintain nPR is responsible for embryonic
oligodendrogenesis and early postnatal OPC proliferation and differentiation,
questioning only the isoform of nPR involved51. Yet my data from Nes-treated cerebellar
slices from PRKO mice suggests nPR may not even be necessary at all for P4 to
influence early myelin development in terms of speed and robustness.
3.3 Complexities of CNS P4 signaling
3.3.1 P4 exerts CNS effects via numerous distinct receptors
In my ultimate aim to deduce the signaling pathway underlying P4-mediated
myelin regeneration, the receptor(s) involved in this pathway must be identified.
However, there are at least 11 confirmed functional P4 receptors including the
traditional nPR for which Nes is a potent agonist, along with multiple membraneassociated progesterone receptors (MAPRs) and 7-transmembrane domain receptors
(Figure 3.7)160. nPR, the most thoroughly studied of the P4 receptors by far, exists in
alpha and beta isoforms, the former of which is simply a truncated version of the latter.
The beta form has been identified in the cytoplasm in addition to the nucleus28. The
seven-transmembrane class 2 progestin and adipoQ receptor (TMPR) family proteins
Paqr5, Paqr6, Paqr7, Paqr8, and Paqr9 have also been linked to P4 signaling in the
CNS, as have MAPRs progesterone receptor membrane components 1 and 2 (Pgrmc1
and Pgrmc2), neudesin neurotrophic factor (Nenf), and neuferricin (Cyb5d2)110,161. The
MAPRs, also referred to as b5-like heme-/steroid-binding protein family members, are
proposed to regulate iron transport within the CNS. Pgrmc1 and Pgrmc2 shuttle iron
from the mitochondria to the nucleus162. Iron, in turn, is a critical co-factor in lipid (i.e.
myelin) biosynthesis, and facilitates oxidative metabolism in oligodendrocytes163. Nenf
and Cyb5d2 both exert neurotrophic effects via binding to iron164.
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Figure 3.7: Cellar localization of numerous P4 receptors. There are currently 11 P4 receptors
with documented CNS expression. The classical nuclear receptor, here denoted nPR, exists in two
discrete isoforms. Structurally, nPR-alpha is a truncated version of nPR-beta. Spatially, nPR-alpha is
strictly localized to the nucleus, while nPR-beta can be found in the cytoplasm as well. Five of the
TMPR proteins, PAQR5, 6, 7, 8, and 9, as well as b5-like heme-/steroid-binding protein family
members PGRMC1, PGRMC2, neudesin, and neuferricin have also been shown to mediate P4
signaling.

Curious as to which of these numerous P4 receptors are actually expressed in
the CNS, I consulted the Barres Brain Atlas database of differential gene expression in
the brain available online. To create this resource, neurons, astrocytes, microglia,
endothelial cells, pericytes, and oligodendrocytes at successive stages of maturation
were purified from mouse cortex and subject to RNA-Seq to generate a high-resolution
transcriptome database of over 22,000 genes. In my semi-quantitative extrapolation of
the graphical data provided on the Barres Brain Atlas website, I found that RNA coding
for all 11 of the P4 receptors described above is present to varying degrees in at least
one stage of oligodendrocyte development (Table 3.2)165.
Table 3.2: Smmary of Barres Brain Atlas RNA-Seq data of P4 receptor expression in
oligodendrocytes.

+ = low expression, ++ = moderate expression, and +++ = high expression of RNA in human brain.

To conduct an independent validation of the Barres Brain Atlas data, I performed
an analysis to quantify translated RNAs associated with each individual P4 receptor in
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murine oligodendrocytes in collaboration with Eric Schmidt of the Heintz lab. Such data
is generated through translating ribosome affinity purification using the bacteria artificial
chromosome (bacTRAP), an elegant method developed in the Greengard and Heintz
labs to isolate translated RNAs in specific cell populations within the brain. Briefly,
expression of an eGFP-tagged L10 ribosomal transgene in whole animals labels
polysomes that can be immunoprecipitated with an anti-eGFP antibody, and analyzed
via RNA-Seq to generate translational profiles from discrete cell types166. Cmtm5, CNP,
and Olig2 are the three currently available oligodendrocyte-specific bacTRAP mouse
lines. Due to logistical issues of low expression and male sterility in the Cmtm5 and
CNP lines, respectively, I chose to focus on the Olig2 line in an effort to gain clarity on
which P4 receptor(s) should be the focus of my subsequent studies (Figure 3.8).

Figure 3.8: bacTRAP technique. The bacTRAP method relies on the immunoprecipitation of
labeled polysomes for subsequent RNA-Seq analysis. This sagittal section from the Olig2
oligodendrocyte-specific bacTRAP mouse line illustrates Olig2 expression by OPCs and mature
oligodendrocyte processes, both of which contain clusters of ribosomes. The magnified section is an
enlargement of the heavily myelinated corpus callosum, in which interfascicular compact white
matter is linearly organized167.

Previous assessments of microarray data from the Olig2 bacTRAP line highlight
the presence of both P4 receptors and additional genes relevant to P4 synthesis and
metabolism in oligodendrocytes. Multiple P4 receptors including Paqr8, Cyb5d2, and
Nenf are enriched in oligodendrocytes as compared to whole brain with fold changes
greater than 1.5 (Figure 3.9). Interestingly, Paqr8 is linked to neurite outgrowth and ERK
phosphorylation, which has been implicated in the regulation of new myelin production
as well as myelin sheath thickness relative to axonal diameter during
remyelination28,113,114,168-170. The heme-binding proteins Nenf and Cyb5d2 are abundant
in oligodendrocytes, where iron delivery is crucial to myelination. Injury and/or stress
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likely impacts receptor expression, as upregulated Paqr7 has been detected in
oligodendrocytes following TBI171. In addition to receptors, enzymes necessary for P4
synthesis and metabolism including diazepam binding inhibitor (Dbi), 5α-reductase
(Srd5a1 and Srd5a3), 3β-hydroxysteroid dehydrogenase (Hsd3b7), and cytochrome
P450 (Cyp11a1) are significantly enriched in oligodendrocytes compared to whole brain.
Srd5a1, Srd5a3, and Hsd3b7 are constitutively expressed in the human brain
throughout life49,55,59,130,172,173. This high concentration of P4-related genes in
oligodendrocytes is encouraging in the sense that myelin-producing cells are also
equipped with the machinery to produce and sustain P4 levels (Figure 3.9, Table 3.3).
The Barres Brain Atlas confirms enrichment of many genes implicated in P4
synthesis and signaling in oligodendrocytes as compared to other neural cell types.
Expression of the P4 receptor progestin and adipoQ receptor 8 (Paqr8) is restricted to
the nervous system and greatly elevated in oligodendrocytes, with a 70.673-fold change
in newly formed oligodendrocytes versus microglia, and 6.669- and 65.977-fold changes
in myelinating oligodendrocytes versus neurons and microglia, respectively. Additional
genes involved in P4 synthesis from cholesterol are highly enriched in OPCs as
opposed to more mature forms of oligodendrocytes. Cyp4f15, Cyp1b1, Hsd11b1, and
Tspo2 are expressed 41.54-, 29.295-, 23.401-, and 11.587-fold, respectively, in OPCs
as opposed to newly formed and/or myelinating oligodendrocytes. Cyp4f15, Cyp1b1,
and Hsd11b1 encode enzymes required in the production of certain lipids such as
myelin in the CNS, and Tspo2 protein products mediate cholesterol targeting and
trafficking that facilitates myelin production. While this expression data is certainly
compelling, expression levels do not necessarily correspond to the magnitude of the
associated cellular impact. Hence, the P4 receptors that fluctuate significantly in
expression during different developmental stages are of particular interest.
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Figure 3.9: P4 receptor-related genes enriched in oligodendrocytes vs whole brain. This
scatter plot is derived from microarray data on Olig2-bacTRAP mice. The x-axis reflects gene
expression in oligodendrocytes, and the input expression on the y-axis represents whole brain. The
dotted lines indicate 2-fold changes in gene expression. The genes highlighted in green with a
minimum of 1.5-fold greater expression in oligodendrocytes alone than whole brain are crucial to
proper P4 synthesis and functional signaling.
Table 3.3: P4-related genes enriched in oligodendrocytes vs whole brain.

Gene

Protein

Function

logFC

Adj. P
Value

Paqr8

PAQR8

P4 Receptor

1.055056

0.207838

Nenf

Neudesin

P4 Receptor

0.72844

0.286415

Cyb5d2

Neuferricin

P4 Receptor

2.248932

0.001114

Cyp11a1

p450scc

P4 Synthesis

3.838916

0.001652

Srd5a1

5α-reductase 1

P4 Metabolism

3.345268

0.000831

Srd5a3

5α-reductase 3

P4 Metabolism

1.916009

0.003233

Hsd3b7

3β-HSD

P4 Metabolism

2.711691

0.007422

Included here are P4 receptors and other associated genes enriched in oligodendrocytes vs
whole brain, with fold changes of greater than 1.5, or logFC > 0.585. Adjusted p values are
also included, and those <0.05 highlighted in green have the highest confidence of
enrichment.

36

3.3.2 Discussion
One previously alluded to and pivotal aspect of P4 signaling is its rapid
metabolism. Despite its short half-life in blood on the order of minutes, P4-induced
effects in tissues persist after the hormone has been cleared from serum. These data
suggest that P4 metabolites may be at least partially responsible for such effects. In
fact, many contributors to the P4 literature concede they cannot experimentally
differentiate between P4 and one of its metabolites, ALLO, due to an inability to
physiologically isolate one from the other. Among the neuroprotective properties
commonly attributed to ALLO are attenuated BBB dysfunction and coagulopathy
following ischemic events, decreased neuroinflammation in disease states, and
regenerative potential in AD and MS (Figure 3.10)94,174-176.

Figure 3.10: ALLO actions in the CNS. ALLO in particular has received much attention in the
literature for its neuroprotective properties including upregulation of myelin genes, decreased
inflammation and microglial activation, promotion of neurogenesis, and decreased BBB permeability94.

While OPCs generate large quantities of the immediate P4 precursor, Preg,
astrocytes are the primary P4 producers in the CNS (Figure 3.11)55,57,58,127. The unique
autocrine and paracrine signaling of P4 and its metabolites, namely ALLO, emphasize a
profound obstacle to determining the necessity for P4 in CNS development: widespread
endogenous generation of P4 throughout life from the adrenal glands, gonads, and CNS
itself via neurons and glial cells. Due to pervasive production of neurosteroids and their
capacity to infiltrate the BBB when dissociated from albumin, prior studies merely
speculate as to mechanisms of P4 activity on myelin development and pathology.
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Figure 3.11: P4 metabolism in the CNS. OPCs (yellow) produce high quantities of the immediate
P4 precursor, Preg, while astrocytes (blue) are the primary producers of P4. Peripherally, P4 is
typically bound to albumin, leaving little free P4 in the blood. However, free P4 easily crosses the
BBB via transmembrane diffusion177.

These limitations prompted me to shift my experimental paradigm to one entirely
devoid of any P4, whether it be endogenous or exogenous. I considered this a more
rigorous strategy to determine whether or not the hormone is required for myelination.
Thorough research of the neurosteroid synthesis pathway aided my evaluation of
candidate enzymes to inhibit in my hypothetical P4-free mouse. I chose p450scc,
encoded by the CYP11A1 gene, as it initiates hormone synthesis by converting
cholesterol into Preg, the immediate precursor to P4178. Mice lacking functional p450scc
are unable to produce any neurosteroids at all, and not surprisingly, die shortly after
birth. According to the literature, they can be rescued with a daily injection of a steroid
cocktail consisting of dexamethasone 21-phosphate, prednisolone, and fludrocortisone
acetate for about one postnatal week; yet I was unable to reproduce this rescue
procedure179. The Jackson Laboratory has a cryopreserved Cyp11a1-GFP-Cre strain in
which a GFP-Cre cassette (GC) was inserted into the Cyp11a1 locus (JAX stock
#010988). This Cyp11a1-GC strain, traditionally utilized in the context of genitourinary
and mammary development, can be manipulated to produce a Cyp11a1 KO mouse180.
There are no records indicating any relevant CNS phenotypes have been evaluated. I
ordered and cryo-recovered this strain with the intent to perform a comprehensive
analysis of the CNS architecture.

38

CHAPTER 4: Implementation of a Neurosteroid-free Model System

4.1 Characterization of Cyp11a1 KO mouse
4.1.1 Establishment of Cyp11a1-GC transgenic mouse line
PRKO mice were created by the insertion of a targeting vector containing a GFPCre cassette (GC) and FRT site-flanked kanamycin and neomycin resistance cassette
into the first coding exon of the endogenous Cyp11a1 gene immediately following the
ATG translation initiation codon (Figure 4.1)180. This entire construct essentially serves
as one large insertional mutation, thereby allowing the generation of Cyp11a1-null
homozygotes.

Figure 4.1: Genetic construct of Cyp11a-GC mice. A 7.9 kb genomic fragment of Cyp11a1
(containing the first four exons) was gap repaired by homologous recombination onto pDTA.4B from
a BAC clone obtained from Sanger Institute. A targeting vector containing a GFP-Cre cassette (GC)
and FRT site flanked Kanamycin/neomycin selection cassette was used to disrupt the exon
containing the ATG translation start-site. Following electroporation, correctly targeted embryonic
stem cells were injected into recipient blastocysts. The resulting chimeric animals were crossed to
C57BL/6 mice180.

Members of Dr. Bon-chu Chung’s lab at the Institute of Molecular Biology,
Academia Sinica in Taiwan provided primer sequences and a specific PCR protocol for
genotyping. The inclusion of three primers yielded a 368-bp amplicon corresponding to
the WT allele and a 296-bp amplicon corresponding to the mutant allele (Figure 4.2).
Seven Het and one WT mouse of the B6;129P-Cyp11a1tm1(GFP/cre)Pzg/J strain (Stock No.
010988) were cryorecovered and transferred from the Jackson Laboratory to Weill
Cornell Medicine. Due to early postnatal death of homozygous KOs, Het males and
females were crossed to generate WT, Het, and homozygous KO offspring.
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Figure 4.2: Genotyping of Cyp11a1-GC mice. Three primers were combined in the same PCR
reaction to generate a 296-bp amplicon corresponding to the mutant allele and a 368-bp amplicon
for the WT allele. Presence of both amplicons indicates a Het.

4.1.2 Documented physiological abnormalities
Four Cyp11a1-deficinet mouse models in addition to the B6;129PCyp11a1tm1(GFP/cre)Pzg/J strain I’m using here have undergone primarily adrenal and
reproductive characterization. Table 4.1 lists the nomenclature for each of these strains,
along with the nature of the mutations and institutional sources. Despite the abundance
of abnormalities associated with such mutations, it is immediately apparent that no
methodical evaluation of the nervous system has been attempted in any of the
transgenic strains. The few CNS-relevant phenotypes that have been identified were not
directly derived from targeted analyses of the CNS, highlighting the need for clarification
of the roles for neurosteroids like P4 in brain and spinal cord development and
physiology. Table 4.2 provides a comprehensive overview of confirmed phenotypes
attributed to Cyp11a1 deficiency categorized at the functional level. Check marks
indicate the phenotype has been confirmed in the respective strain. Dashes indicate the
phenotype was specifically evaluated but not observed. Blank cells indicate the specific
phenotype was not addressed. Phenotypes highlighted in red are relevant, either
directly or indirectly, to the CNS.
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Table 4.1: Existing Cyp11a1-deficient mouse models.

*Note that these sources only probed for p450scc protein expression in endocrine and reproductive
glands, and not the CNS133,180-185.
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Table 4.2: Abnormal phenotypes in Cyp11a1-deficient mouse strains.
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Neonatal Lethality

Behavioral
Cellular
Cardiovascular
Immune
PNS

Phenotype
Strain 1 Strain 2 Strain 3 Strain 4 Strain 5
Abnormal adrenal gland physiology
✔️
✔️
✔️
Abnormal adrenal gland morpholgy
✔️
✔️
✔️
✔️
Abnormal adrenal cortex morphology
✔️
✔️
Abnormal adrenocortical cell morhology
✔️
Absent adrenal chromaffin cells
✔️
Abnormal zona fasciculate morphology
✔️
Abnormal zona glomerulosa morphology
✔️
Enlarged adrenal glands
➖
✔️
Small adrenal glands
✔️
➖
Enlarged adrenocortical cells
✔️
Excessive lipid (cholesterol) accumulation
✔️
✔️
✔️
Altered adrenal circadian rhythms
✔️
Reproductive system abnormalities
✔️
✔️
Absent bulbourethral gland
✔️
➖
Absent prostate gland
✔️
➖
Abnormal seminiferous tubule morphology
✔️
Small testes
✔️
Ectopic CYP21 expression in testes
✔️
Abnormal spermatogenesis
✔️
➖
Absent scrotum
✔️
➖
Abnormal epididymis epithelium morphology
✔️
Absent coagulating gland
✔️
➖
Abset ampulla
✔️
➖
Abnormal vas deferens morphology
✔️
Secondary male to female sex reversal
✔️
➖
Increased circulating adrenocorticotropin
✔️
✔️
✔️
Decreased adrenaline
✔️
Decreased noradrenaline
✔️
Abnormal corticosterone
✔️
✔️
✔️
Decreased circulating aldosterone
✔️
Abnormal circulating sodium
✔️
Abnormal circulating potassium
✔️
Increased urinary sodium
✔️
Placental defects
➖
✔️
Postnatal growth retardation
✔️
➖
Muscular atrophy
✔️
➖
Complete penetrance
✔️
✔️
➖
Incomplete penetrance
➖
✔️
✔️
Dilated sinusoidal spaces
✔️
Dilated bile duct
✔️
Abnormal optic cup morphology
✔️
✔️
Retrolental blood
✔️
Decreased food intake
✔️
Hypoactivity
✔️
Abnormal mitochondrion morphology
✔️
✔️
Hemopericardium
✔️
Decreased T cell apoptosis under stress
✔️
Thin hypoglossal nerve
✔️
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Nervous system phenotypes listed in red in Table 4.2 include absent adrenal
chromaffin cells, abnormal optic cup morphology, and retrolental bleeding. Chromaffin
cells innervating the adrenal gland and sympathetic nervous system are responsible for
the body’s involuntary catecholamine response to different types of stressors,
colloquially known as the “fight or flight” response. Fear- or stress-induced input from
splanchnic nerves promotes adrenal chromaffin cells to secrete hormones such as
epinephrine (adrenaline), norepinephrine (noradrenaline), dopamine, enkephalin, and
enkephalin-containing peptides, amongst others, into the bloodstream186. Without
functional adrenal chromaffin cells, Cyp11a1-deficient mice are particularly vulnerable to
various environmental and physiological stressors. The phenotypes most directly
related to the CNS involve ocular defects. As altered optic disc morphology is visible to
the naked eye as early as E12.5 based on my dissection experience, it is not surprising
that mice lacking sufficient p450scc protein exhibit delayed optic cup development185.
Retrolental or retinal bleeding is most commonly a result of premature birth, in which
case retinal blood vessels fail to grow properly, if at all, into the back of the eye. These
fragile vessels are prone to leakiness, leading to bleeding that can precede retinal
detachment and even blindness187.
Abnormal mitochondrial structure, though not in and of itself a CNS phenotype,
may be applicable throughout the entire body at the cellular level. According to previous
studies of enteroendocrine cell-resident mitochondria, Cyp11a1 deficiency interferes
with the cell’s inherent steroidogenic capacity by reducing the number of cristae, thus
eliminating critical opportunities for cholesterol conversion at the mitochondrial
membrane. Decreased and at times completely absent cristae are evident as early as
E9.5 in the placenta and E18.5 in the adrenal gland in mice, demonstrating the
autocrine nature by which p450scc is both required to generate normal cristae, and
subsequently dependent on maximally efficient mitochondria to facilitate expeditious
steroidogenesis133. Similar adrenal mitochondrial malformations were noted in a mouse
strain with a mild mutation in the Cyp11a1 promoter that evades neonatal lethality as
late as postnatal 18 weeks184. Again, these studies have failed to incorporate neural
mitochondria thus far, reiterating the dearth of experimental efforts centered on the
presumably wide-ranging consequences of CNS cells deprived of steroidogenic
capability.
4.1.3 Discussion
Despite the current lack of data on neurosteroid contributions to CNS
development, the various phenotypic abnormalities identified above offer compelling
insights into the vast potential for discovery in this nascent field. The established
presence of neurosteroid hormones throughout life is remarkably apparent as early as
neural crest formation. Major vertebrate neural crest derivatives are diverse, including
PNS cells, endocrine and paraendocrine cells, pigment cells, facial cartilage and bone,
and connective tissue. As illustrated in Figure 4.3, these derivatives occupy transient
regions of the neural crest before migrating to fulfill their destined cell fates upon neural
tube closure. These regions are defined by the classes of cells and tissue they
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propagate. The cranial or cephalic region yields the bone and cartilage of the face and
neck, bones of the middle ear and jaw, cranial neurons, facial glia and connective
tissue, thymic cells, odontoblasts of tooth primordia, and epidermal pigment cells.
Parasympathetic ganglia of the gut can be traced to the vagal and sacral regions.
Somites one through three comprise cardiac neural crest cells necessary to divide the
aorta and pulmonary artery. The epinephrine-producing chromaffin cells that fail to
populate the adrenal medulla in Cyp11a1-deificent mice are typically born within the
most expansive neural crest region, the trunk. Somites contained within the boundaries
of the trunk neural crest give rise to sympathetic neurons, a subset of which (18 through
24) generate the medulla portion of the adrenal gland188.

Figure 4.3: Vertebrate neural crest fate map. Vertebrate neural crest derivatives are confined to
the distinct regions delineated by numerical somites. Of particular interest with respect to Cyp11a1
deficiency are the adrenal chromaffin cells, which arise from somites 18 through 24 within the trunk
region.

Ventrolateral migration of trunk neural crest cells driven by extracellular matrix
(ECM) components among other migratory cues allows for final differentiation189. This
process is highly glucocorticoid-dependent at multiple defining points along the pathway
to adrenomedullary specification (Figure 4.4). First, glucocorticoids are required to
inhibit factors that, in the presence of fibroblast growth factor 2 (FGF2) and nerve
growth factor (NGF), would otherwise promote differentiation into sympathetic neurons.
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Cells that evade neuronal specification then further rely on glucocorticoids to activate
enzymes associated with their newfound adrenomedullary fate190. The capacity for
catecholamine synthesis is attributed to two glucocorticoid-induced enzymes in
particular. Interestingly, tyrosine hydroxylase (TH), indicative of proper trunk cell
migration into the medulla, is expressed at normal levels in the Cyp11a1-deficient
adrenal gland. However, expression of phenylethanolamine-N-methyltransferase
(PMNT), the enzyme that enables catecholamine synthesis and thus serves as a
classical marker for adrenergic chromaffin cells, is not detectable in the absence of
Cyp11a1133. This suggests that in Cyp11a1-deficient mice, maternal glucocorticoids
delivered via the placenta are sufficient to generate adrenal chromaffin precursor cells.
Maturation into fully functional chromaffin cells capable of catecholamine synthesis,
however, must demand additional sources of endogenous embryonic glucocorticoids.

Figure 4.4: Adrenal chromaffin cell differentiation. The red asterisk indicates the point at which a
presumed lack of adequate glucocorticoids prevents PMNT expression in Cyp11a1 mutant mice,
rendering chromaffin precursor cells unable to produce catecholamines critical to the stress
response such as epinephrine.

In terms of the CNS proper, the retinal and mitochondrial defects ascribed to
Cyp11a1-deificient mouse strains draw striking parallels to morphological patterns
characteristic of demyelinating diseases like MS. Mitochondrial alterations have been
documented in oligodendrocytes, peripheral blood mononuclear cells (PBMCs), and
peripheral lymphocytes from MS patients. De Rasmo et al. found a high incidence of
PBMC optic atrophy 1 (OPA1) deregulation in the MS cases. This protein is vital to
mitochondrial health, mediating cellular bioenergetics, cristae architecture, and release
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of pro-apoptotic factors when necessary191. The abnormal cristae phenotype associated
with MS mirrors that of the Cyp11a1-deficient adrenal gland, suggesting similar issues
with general steroidogenesis. Oligodendrocytes are particularly vulnerable to
mitochondrial dysfunction due to the exceptionally high energy expended producing
myelin as well as releasing lactate to drive neuronal action potentials. The brain milieu
of chronic inflammation and demyelination leads to redistribution of ion channels
populating the Nodes of Ranvier. Consequent disturbances to the propagation of the
electrochemical gradient along the neuron increase ATP consumption, thereby forcing
compensatory mechanisms in the effected mitochondria. As such, increased
oligodendroglial mitochondria with a swollen appearance and altered cell morphology
often accumulate in the context of MS. A vicious cycle of oxidative stress and ongoing
inflammation perpetuate further mitochondrial damage, until the energy imbalance is so
great that action potentials are not maintained192. The ensuing buildup of sodium in the
cytoplasm forces calcium transfer into the cell which in turn activates an apoptotic
response. The resulting and often irreversible neuronal death and Wallerian
degeneration both contribute to MS pathology.
As the leading cause of cell death in neurodegenerative conditions, mitochondrial
dysfunction is certainly a worthy therapeutic target193. The defective cristae in the
Cyp11a1-deficient mice emphasize the vitality of steroidogenesis to maintaining
mitochondrial architecture and dynamics. Such defects, if present in the MS-afflicted
CNS, would only exacerbate the already debilitating cascade of energy depletion in
oligodendrocyte metabolism and the inevitable neurodegeneration that follows. Again, a
thorough assessment of the embryonic rodent CNS in the absence of p450scc protein is
necessary to determine whether or not neurosteroid deficiency can elicit mitochondrial
damage in future myelinating oligodendrocytes.
4.2 Anatomical analysis of Cyp11a1-GC transgenic mouse
4.2.1 Gross embryonic physical assessment
To this end, E18.5 Cyp11a1-GC transgenic mouse embryos were subject to
retrospective genotyping and gross physical assessment. Traits including size, weight,
and overall morphology were evaluated. Counter to my initial expectations, the absence
of significant trends in size precluded the ability to predict genotype by the naked eye
alone. Similarly, the slight variation in weights of the entire embryos and their respective
placentae and brains was a universal characteristic of the litter at large that was not
strictly correlated with genotype (Figure 4.5, A). One trend that did become apparent
over the course of multiple embryonic dissections with respect to general anatomy was
abnormal optic disc morphology (Figure 4.5, B), consistent with previous reports
summarized in Table 4.2180-182,185. This defect was initially visible at E12.5.
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A.

B.

Figure 4.5: Summary of morphological comparisons across embryonic B6;129PCyp11a1tm1(GFP/cre)Pzg/J genotypes. No significant weight differences exist at E18.5 (A). Results
expressed as Mean ± STDEV, n = 12 embryos per genotype. However, Cyp11a1-deficient embryos
as young as E12.5 appear to lack proper optic discs (B). The normally developing optic disc circled
in red in the WT embryo is not present in the KO embryo.

4.2.2 Phenotypes associated with perinatal lethality
H&E staining of the E18.5 Cyp11a1-GC transgenic embryos revealed several
factors contributing to the perinatal lethality seen in the homozygous KO mouse. The
most prominent defects in the KO animals are adrenal gland abnormalities previously
described in the literature133,180,183,184. The three magnifications provided in Figure 4.6 of
the adrenal glands of WT compared to KO mice depict both broad architectural as well
as cellular damage. In contrast to the WT adrenal glands featuring discrete
corticomedullary regions, the disorganized KO adrenal glands lack such anatomical
boundaries. Cortical cells in these animals show rampant signs of degeneration
including cytoplasmic granularity. The high magnification image of the KO tissue in
Figure 4.6 exemplifies the progressive cellular degeneration initiated by irreversible
condensation of nuclear chromatin, or pyknosis, preceding necrotic or apoptotic
cascades. These pyknotic cells inevitably undergo subsequent karyorrhexis, or
destructive nuclear fragmentation, leaving condensed chromatin dispersed randomly
throughout the cytoplasm. Karyorrhexis events manifest as variably sized, round, clear,
and colorless cytoplasmic holes as labeled in Figure 4.6. Cell shrinkage alongside
cytoplasmic hypereosinophilia are further hallmarks of the adrenal insufficiency
attributed to the KO mice with grave functional consequences. Under normal conditions,
the adrenal gland secretes abundant glucocorticoids which in turn inhibit white blood
cell proliferation and survival. Inadequate adrenal glucocorticoid stores yield unusually
high numbers of eosinophils with the potential to harm surrounding tissue. Staining for
TUJ1, the primary neuron-specific component of microtubules, labels the compact
bundles of chromaffin cells inhabiting the WT adrenal tissue. Their counterparts in the
KO tissue, however, are markedly fewer in number and more dispersed throughout the
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entirety of the adrenal gland (Figure 4.6). As stated above, the absence of chromaffin
cells is one of the few neural phenotypes previously identified in Cyp11a1-deficient
mice. While these cells are present to some extent according to the
immunohistochemistry (IHC) images in Figure 4.6, the loss of medulla-specific
localization likely inhibits their functionality of releasing the neurohormones epinephrine
and norepinephrine into the bloodstream186.

Figure 4.6: Embryonic adrenal gland abnormalities in homozygous KO E18.5 B6;129PCyp11a1tm1(GFP/cre)Pzg/J mice. This H&E analysis of the adrenal gland not only indicates indistinct
boundaries defining the cortex and medulla in the KO, but rampant cell death of cortical cells as well.
Arrows in bottom right provide examples of the pyknosis (yellow), cytoplasmic vacuolation (blue),
and karyorrhexis (green) associated apoptotic and/or necrotic cascades.

While the aforementioned adrenal defects are perhaps the defining phenotype of
the Cyp11a1-GC homozygous KO embryo, liver abnormalities are also likely to play a
role in perinatal lethality. The top horizontal panel of Figure 4.7 illustrates significantly
decreased cytoplasmic vacuolation of hepatocytes originating from KO as compared to
WT animals. This observation suggests hindered organ metabolism in the liver of KO
mice in which hepatocytes are unable to properly absorb glycogen. Alternatively or
additionally, hepatocytes’ failure to meet the liver’s metabolic needs may inhibit an
effective stress response at the cellular level. This novel cytoplasmic vacuolation
phenotype is distinct from previously documented dilated sinusoidal spaces. Dynamic
microvascular hepatic structures serve as the capillaries and venules of the liver. The
swelling cited in the literature points to decreased blood cell production, as the liver is a
major site of extramedullary hematopoiesis during development185. Sinusoidal dilation
might also emerge following hepatocyte atrophy in some cases, though this has not
been confirmed.
The H&E staining revealed yet another, likely more acute cause of perinatal
death in KO animals. Incredibly robust lung abnormalities in bronchial expansion
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suggest marked difficulty with inspiration immediately following birth. The bottom
horizontal panel of Figure 4.7 illustrates the great extent to which airway expansion is
restricted in the lungs of KO mice. This novel finding, though yet to be reported, adds
respiratory inhibition to the slew of physiological stressors certain to prevent perinatal
survival. One proposed mechanism that might impair proper airway expansion involves
a failure to generate and mobilize sufficient surfactant molecules in the absence of
endogenous glucocorticoids. Typically, these molecules reduce surface tension via
interposition between water molecules, thereby effectively creating alveolar space
requisite for normal respiration. The ensuing molecular events entail a carefully
orchestrated sequence among pulmonary-resident steroid hormones and their related
receptors and metabolic enzymes. Specifically, expression of p450scc, the enzyme
produced from the CYP11A1 gene, promotes the release of abundant glucocorticoids at
E15. The resultant activation of their respective glucocorticoid receptors around E16
allows for the conversion of fetal lung glycogen to surfactant by E17194. The surfactant
surge is crucial for airway expansion to begin at this developmental stage. By E18.5,
prominent bronchial expansion should be visible, as seen in the H&E staining of the
WT, but not KO, mouse lung (Figure 4.7). Notably, all enzymes necessary for
glucocorticoid synthesis are expressed in pulmonary tissue at E15 just prior to the
glucocorticoid surge, including StAR, 3ß-hydroxysteroid dehydrogenase, 21hydroxylase, and 11ß-hydroxylase195. The presence of all of these enzymes
simultaneously supports the glucocorticoid-driven model of surfactant-induced airway
expansion during normal lung development.
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Figure 4.7: Embryonic liver and lung abnormalities in homozygous KO E18.5 B6;129PCyp11a1tm1(GFP/cre)Pzg/J mice. H&E analysis of the liver suggests that KO animals experience altered
organ metabolism due to the markedly decreased cytoplasmic vacuolation of hepatocytes compared
to their WT counterparts (top panel). H&E staining additionally offers novel insight into a pulmonary
phenotype in the KOs of highly inadequate airway expansion (bottom panel). The ensuing
respiratory issues likely contribute to the robust neonatal lethality in these animals.

4.2.3 Brain histological analysis
A comprehensive histological analysis of the WT and Cyp11a1-null brains
unexpectedly yielded no significant anatomical differences between the two genotypes.
The similar H&E profiles eliminate the suspicion of anatomical abnormalities in the KO
brain. The cresyl violet and TUJ1 staining do not provide any indication of atypical
neural architecture in the KO brain. Finally, the lack of differences in cleaved caspase-3
staining suggest developmental apoptotic patterns in the brain at large have not gone
awry in the KO brain either by E18.5 (Figure 4.8).
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Figure 4.8: Brain anatomy in homozygous KO E18.5 B6;129P-Cyp11a1tm1(GFP/cre)Pzg/J mice. No
significant differences are observed distinguishing WT from Cyp11a1 KO E 18.5 brain tissue by
H&E, cresyl violet, TUJ1, or cleaved caspase-3 staining.

4.2.4 Spinal cord histological analysis
Much like the brain, the spinal cord is anatomically comparable between WT and
Cyp11a1 KO E18.5 brain tissue according to H&E in addition to TUJ1 staining (Figure
4.9). The virtually identical spatial localization of cells and neurons in both genotypes
implies the absence of endogenous neurosteroid production does not drastically
compromise anatomical brain development, at least up to E18.5.
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Figure 4.9: Spinal cord anatomy in homozygous KO E18.5 B6;129P-Cyp11a1tm1(GFP/cre)Pzg/J
mice. No significant differences are observed distinguishing WT from Cyp11a1 KO E 18.5 spinal
cord tissue by H&E or TUJ1 staining.

4.2.5 CNS oligodendrocyte immunohistochemistry
Despite the absence of any glaring structural brain abnormalities, it is
conceivable that oligodendrocyte biology might vary based on the extent of local
neurosteroid synthesis. However, no differences in oligodendrocyte frequency or spatial
organization emerge from nuclear Olig2 or MBP plasma membrane staining (Figure
4.10).
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Figure 4.10: Oligodendrocyte immunohistochemistry in homozygous KO E18.5 B6;129PCyp11a1tm1(GFP/cre)Pzg/J mice. Coronal brain sections taken from E18.5 CYP11A1 KO mice were
histologically stained for oligodendrocyte markers Olig2 and MBP. Positive staining is indicated in
brown. No significant localization or quantitative differences are observed distinguishing WT from
Cyp11a1 KO E18.5 CNS tissue by Olig2 (A) or MBP (B) staining.
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4.2.6 Discussion
The novel histological analysis of the homozygous B6;129PCyp11a1tm1(GFP/cre)Pzg/J mouse CNS described in detail above holds various implications
for the roles of neurosteroid hormones in prenatal brain and spinal cord development.
Although the images do not support anatomical, neural, or oligodendroglial phenotypes
in the late embryonic Cyp11a1-null CNS, the perinatal lethality of the homozygous
mutants indicates endogenous neurosteroid production is in fact requisite for survival.
Prenatal exposure to maternal neurosteroids via the placenta must compensate for the
inability of the KOs to synthesize their own. As soon as the pups are isolated from that
rich source of neurosteroids upon birth, their suddenly steroid-deprived bodies are
unable to sustain life. Given the de novo production of neurosteroids in glial cells, the
fact that the brain and spinal cord develop normally without the enzymatic activity of
p450scc is quite remarkable. Histological analyses on pups obtained in the minutes to
hours between birth and death might be enlightening in terms of discerning the timeline
of CNS and peripheral changes due to denied access to maternal neurosteroid pools.
The traditional oligodendrocyte markers Olig2 and MBP rely on spatial and
temporal patterning to promote distinct waves of OPC induction and eventually support
OPC maturation into myelinating cells. Olig2 appears around E9 in mice to initiate the
beginning stages of oligodendrocyte specification. By E13, ventral Olig2 expression
delineates the origin of OPC generation and subsequent migration196. The spinal cord
images in Figure 4.10, A reflect diffuse migration of Olig2-positive OPCs throughout the
WT and KO explants alike. Early localization of brain Olig 2 to the ventricular zone (VZ)
and subventricular zone (SVZ) suggests its involvement in the fate specification of
neural progenitor cells into oligodendrocytes as opposed to motor neurons197.
Shortly before birth around E18.5, the timepoint at which I collected tissue for this
work, OPCs populating the spinal cord begin to express MBP. Notably, these
oligodendrocytes undergo maturation and ensheath their first axons within the ventral
and dorsal funiculi. Further migration out of the funiculi and into surrounding white and
gray matter increases postnatally198,199. Consistent with this established route of
oligodendrocyte genesis and proliferation, both WT and KO spinal cord explants
depicted in Figure 4.10, B feature MBP-positive cells lining the ventral rim of the tissue.
MBP expression in the brain, however, is typically evident prior to the initiation of spinal
cord myelination, as early as E14 for some embryonic-specific MBP isoforms200.
While the WT versus KO B6;129P-Cyp11a1tm1(GFP/cre)Pzg/J CNS tissue was not
distinguishable by histology, I sought to determine whether or not the same was true of
oligodendrocyte functionality. I intended to conduct cerebellar slice experiments
mirroring those performed with Nes in WT and PRKO mice to evaluate OPC generation,
proliferation, migration, and maturation in steroid-free embryos separated from maternal
neurosteroids at E12.5. My hypothesis that the Cyp11a1 KO mice would fail to undergo
proper developmental myelination was predicated on the knowledge of ample Preg and
P4 synthesis in CNS-resident glial cells, as well as the prominent impacts of Nes
described in the previous chapter on both MBP expression and the wrapping capacity of
cerebellar oligodendrocytes.
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CHAPTER 5: Ex vivo effects of Neurosteroid-free Environment on
Oligodendrocyte Development in Prenatal Mouse Spinal Cord

5.1 Establishment of experimental paradigm to interrogate oligodendrocyte
development in Cyp11a1 KO mouse
5.1.1 Strategies to circumvent perinatal lethality
Theoretically, the cerebellar slice culture system previously implemented to study
Nes effects on oligodendroglial developmental would have been an ideal strategy to
repeat in a completely steroid-free environment. However, the perinatal lethality of the
Cyp11a1 KO mice posed what proved to be an insurmountable obstacle to the
cerebellar slice paradigm, which requires brain tissue from P7 pups. According to the
Chung lab where this transgenic strain originated, daily administration of a steroid
cocktail was sufficient to rescue the pups for approximately one week. This life-saving
combination of glucocorticoids and mineralocorticoids consisted of dexamethasone 21phosphate (glucocorticoid) at 4 µg/mL, prednisone 21-hemisuccinate (glucocorticoid) at
4 µg/mL, and fludrocortisone acetate (glucocorticoid and mineralocorticoid) at 10
µg/mL179. In my hands, subcutaneously injecting this solution into the pups was not
feasible in sesame oil, the recommended solvent. The fragile pups required the use of a
needle with the smallest circumference possible, which did not permit the viscous
steroid cocktail solution to flow freely. My attempts to overcome this impediment by
relying on oils of varying consistencies including corn oil and olive oil proved futile.
Water was the only solvent that I was able to successfully and reliably administer to the
newborn pups through a needle of appropriate size. Unfortunately, the logistics of being
physically present at the time of birth were too cumbersome, and the majority of the KO
pups had already perished by the time I reached the new litter.
As an alternative to injecting the pups, I sought to dissolve the steroid cocktail in
the pregnant female’s drinking water. This was not an efficient long-term solution, as the
steroids eventually come out of solution in water alone. Additionally, I had no way of
controlling dosage, a key factor in ensuring the steroids produced only their intended
effects. Finally, I resorted to injecting females with the steroid cocktail beginning late in
their pregnancies and in the days following birth. My hope was that the steroids would
then transfer to the pups via breastmilk. This method would also eliminate the need for
me to access the KO pups within the first (and last) few minutes of their lives.
Ultimately, none of these approaches achieved the objective of rescuing the Cyp11a1
KO pups to facilitate cerebellar dissections at P7. I therefore turned to a new
experimental paradigm focused on prenatal oligodendrocyte development.
5.1.2 Ex vivo spinal cord explant system
With the shift to the ex vivo spinal cord explant system, I no longer had to take
such painstaking efforts to prolong the short lives of the Cyp11a1 KO pups.
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Oligodendrocytes within such explants undergo spatial and temporal development
under cell culture conditions analogous to that seen in the CNS in vivo149. This
physiological relevance enhanced the validity of the data, thus providing a functional
accompaniment to the previously described histological imaging. Briefly, E12.5 embryos
were dissected from Cyp11a1 female Hets, spinal cords isolated and cut into
approximately 1-mm segments, and explants cultured in hormone-free media until
putative E17.5. The culture media composition was adapted from Vartanian et al., 1999,
and prepared with no phenol red due to its reported estrogenic activity149,201. Extraneous
embryonic tissue was used for retrospective genotyping once the explants were all in
culture.
Much like the cerebellar slice culture system, this spinal cord explant paradigm
allowed for the elimination of maternally derived steroids during a pivotal period of early
oligodendrocyte development from the ventral ventricular zone (VVZ). The Het by Het
breeding scheme necessitated by the perinatal lethality of the KO animals ensured the
ability for each individual litter to contain representatives from all three WT, Het, and KO
genotypes. Of course, this wasn’t always the case, but comparisons across genotypes
from the same litter were made whenever possible. The spinal cord explant protocol
also comes with several inevitable disadvantages, namely difficulty in removing the
delicate cord completely intact and the need to sever the cords by hand as opposed to
in a mechanical tissue chopper such as that used in the cerebellar slice experiments.
That being said, the tissue, whether initially intact or not, was subject to blunt cutting
with a scalpel, and proved rather resilient in culture after enduring such aggressive
manipulation. With respect to maintaining consistent explant length, I learned over time
the optimal size to maximize the probability of adherence and survival in culture.
Excessively thick explants tended to lift off the plate and die, while the thinnest explants
were highly susceptible to breakage and other means of damage throughout the fixation
and staining processes. Taking care to generate explants as uniform in size as
manageable also reduced the likelihood of ascribing legitimacy to apparent phenotypes
directly resulting from variations in tissue thickness.
5.1.3 Optimization of tissue culture protocol
The tissue culture protocol for the spinal cord explants required a fair amount of
troubleshooting as well. Traditionally, explants are positioned in plates coated in
Matrigel matrix with a high concentration of ECM proteins and various growth factors202.
However, these matrices also contain indiscriminate amounts of hormones that could
presumably negate the intentional deprivation of placental steroid hormones. Numerous
trials using coverslips coated in individual as well as different combinations of ECM
proteins failed to reach a desirable adherence rate, severely limiting the data
accumulated from any given experiment. Embedding the explants in a thicker collagen
gel matrix directly in glass-bottom plates compatible with confocal microscopes was not
a viable option either. The gel did not always solidify adequately to hold the explants in
place, often leading to tissue death. Additionally, fluorescent labeling of any tissue that
did survive required unreasonably high concentrations of antibody, and was therefore
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not sustainable to accommodate multiple experiments over an extended period of time.
Ultimately, implementing the same nylon membranes utilized in the cerebellar slice
culture procedure produced the highest proportion of viable tissue sufficiently durable to
withstand the fixation, staining, and imaging steps.
5.1.4 Discussion
Applying the spinal cord explant experimental paradigm to the Cyp11a1 mice
retained all of the benefits of the cerebellar slice system, particularly interrupting the
flow of maternal steroid hormones to the growing embryos, thereby creating a truly
neurosteroid-free environment in the KO animals. Upon resolving several logistical
obstacles to tissue handling and maintenance, I carefully considered oligodendrocyterelated proteins that might be the most informative during the E12.5 to E17.5 window of
development. The oligodendrocyte transcription factor Nkx2.2 and the mature myelin
protein MBP qualified as prime candidates. Nkx2.2 is associated with oligodendrocyte
differentiation from neural progenitor cells (NPCs). The highly conserved transcription
factor is believed to favor differentiation over proliferation by repressing downstream
genes in tandem with corepressors and/or epigenetic factors203. MBP expression right
around E18.5 coincides with oligodendrocyte maturation into myelinating cells. Though
the rate of oligodendrocyte maturation certainly increases substantially over the course
of the first two to four postnatal weeks, MBP expression is observed prior to birth198. I
opted to stain the spinal cord explants for these two proteins in part to complement my
previous Nes work showing marked differences in MBP expression in developing
cerebellar slices from PRKO mice. I also reasoned that the addition of a protein like
Nkx2.2 involved in even earlier stages of oligodendrocyte differentiation might provide
valuable insight into the developmental timepoint at which steroid hormones like P4,
among others, begin to exert their myelin-related effects. These findings would
simultaneously help to clarify the role of neurosteroid hormones at large in CNS
development, and perhaps indicate molecular mechanisms responsible for myelin repair
in disease contexts during which newly generated oligodendrocytes are more amenable
to remyelination than existing oligodendrocytes that survive the insult204.
5.2: Phenotypic analysis of spinal cord oligodendrocyte development in Cyp11a1
KO mouse
5.2.1 Confocal image analysis of spinal cord explants
Confocal microscopy on the spinal cord explant tissue fluorescently labeled with
Nkx2.2 and MBP was conducted on a CaliberID ribbon scanning confocal microscope.
Both Nkx2.2 and MBP exhibited diffuse expression patterns throughout each individual
explant. The Cyp11a1 KO tissue was remarkable in that the MBP staining appeared
highly concentrated along the midline of each explant, almost as if a wave of MBPpositive cells was paralyzed and prevented from migrating (Figure 5.1). This robust
phenotype was visible in all of the KO (n = 7), and none of the WT (n = 9) spinal cord
explants (Figure 5.2).
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Figure 5.1: Cyp11a1 spinal cord explant confocal imaging. Spinal cord explants slices were
dissected from E12.5 Cyp11a1 WT and KO mouse embryos and cultured in the absence of
neurosteroid hormones. Spinal cord explants from Het (not shown) all appeared similar to those from
WT embryos. Tissue was fixed at hypothetical E17.5 and fluorescently stained for MBP (green) and
Nkx2.2 (red). Dense clusters of MBP-positive cells along the midline are visible in the KO explant.
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Figure 5.2: Cyp11a1 KO spinal cord explant confocal imaging. Seen here is MBP (green) and
Nkx2.2 (red) staining as described in Figure 5.1 for three individual KO explants. The abnormal
phenotype featuring densely concentrated MBP-positive cells along the midline is visible in all three
explants.

The MBP fluorescence intensity was slightly elevated in the KO tissue as well,
implying there was no shortage of OPC production in the absence of neurosteroid
hormones. In terms of Nkx2.2, the fluorescence intensity was significantly higher in WT
than KO tissue (Figure 5.3), but the striking bundles of immobile cells as seen with the
MBP staining were not present.
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Figure 5.3: Nkx2.2 and MBP fluorescence intensity in Cyp11a1 spinal cord explants.
Quantification of mean fluorescence intensity of Nkx2.2 and MBP staining in Cyp11a1 WT, Het, and
KO spinal cord explants. Nkx2.2 expression levels were significantly higher in WT versus KO tissue,
while MBP expression levels were lowest in WT tissue, significantly higher in Het tissue, and
somewhat elevated in KO tissue. Results expressed as Mean ± STDEV, p < 0.05 = *, p < 0.01 = **,
p < 0.001 = *** determined by two-way ANOVA with Tukey’s honestly significant difference post-hoc
testing, n = 4-6 spinal cord explants per condition.

5.2.2 Development of line plot quantitative analysis method
In light of the unique phenotype identified in the Cyp11a1 KO spinal cord tissue, I
attempted to quantify the data in a way that would accurately reflect the dense
population of MBP-positive cells along the midline of the tissue. Mean fluorescence
intensity alone, while informative, fails to capture the striking localization pattern seen
here. Aiming to portray the fluorescence intensities at defined intervals across the
length of the explant, I collaborated with Ved Sharma of the Rockefeller University BioImaging Resource Center. We were able to conceive of a strategy to plot these discrete
fluorescence intensities and depict them in a visually intuitive manner. Briefly, raw
confocal images were processed in Imaris software into Z-stack projections, which were
opened in Fiji and normalized to account for variations in tissue size. Five lines of equal
length were drawn perpendicular to the midline across the length of each explant, and
Fiji then generated graphical data points reflecting fluorescence intensities at regular
intervals along the five parallel lines. Figure 5.4 illustrates this initial processing of the
confocal images.
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Figure 5.4: Schematic of line plot analysis strategy. Briefly, confocal images of fixed and stained
spinal cord explants were converted to Z-stack projections from both green (MBP) and red (Nkx2.2)
channels using the Imaris microscopy image analysis software. Line plots were constructed in Fiji
based on the normalized Z-stack projections. For quantification of fluorescence intensities at defined
points throughout the entire explant, five lines of equal length were drawn perpendicular to the
midline across the length of each explant. Fluorescence intensities taken at regular intervals along
the five parallel lines were quantified and listed as a set of (x,y) coordinates, with the x coordinate
reflecting distance along the line in µm, and the y coordinate reflecting the mean fluorescence
intensity at that particular location throughout the depth of the Z-stack.

Ved Sharma composed an algorithm using the RStudio software that
automatically read a spreadsheet of all of the data points compiled in Fiji, and generated
the elegant line plots displayed in Figure 5.5. The solid lines in these plots convey the
mean fluorescence intensities through the Z-stack projection at specific points along the
explant, with the surrounding shaded regions representing the standard error of the
mean. The distinct peaks in the center of the MBP KO plots (Figure 5.5, B) coincide with
the intensely concentrated MBP-positive cells down the midline. A similar yet much
subtler trend is seen in the Nkx2.2 KO explants (Figure 5.5, A). The bar graph in Figure
5.6 quantifies the fold change in peak fluorescence intensity over basal fluorescence
intensity values for each line plot shown in Figure 5.5. For the KO explants, this
maximum value corresponds to the area of the most densely concentrated population of
MBP-positive cells at the midline. Again, modest deviations from the basal fluorescence
intensity are associated with Nkx2.2 in all genotypes, while those deviations are much
more pronounced for the KO MBP tissue.
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Figure 5.5: Line plot analyses of Nkx2.2 and MBP fluorescence intensity in Cyp11a1 spinal
cord explants. Line plot summaries corresponding to each individual explant were produced by an
algorithm created in RStudio by Ved Sharma of the Bio-Imaging Resource Center. The algorithm
was programmed to read the (x,y) coordinates generated through the Fiji analysis described in
Figure 5.4 from an Excel file, and convert them into the final line plots shown here for Nkx2.2 (A) and
MBP (B) staining. The final line plots depict the fluorescence intensity profiles across the length of
the explant, with the solid line representing the mean intensity through the entire Z-stack, and the
shaded regions representing the standard error of the mean.
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Figure 5.6: Nkx2.2 and MBP spinal cord explant maximum fluorescence intensity
comparisons across Cyp11a1 genotypes. Plotted in this bar graph are the ratios of the
fluorescence intensity peaks to the basal fluorescence intensity corresponding to each explant from
Figure 5.5. Basal fluorescence intensity values were approximated based on a line of best fit
spanning the range of fluorescence intensities in the entire line plot, excluding the maximum peak.
The normalized max fluorescence intensity values shown here thus account for variations in basal
fluorescence intensities among the individual tissues. Results are expressed as the mean max
fluorescence intensity values with SD for the two spinal cord explants shown in Figure 5.5 where n =
2 mice per genotype.

5.2.3 Discussion
Myelin development in the spinal cord is classified by two distinct waves of
oligodendrocyte production. The ventral wave begins around E12.5 in mice, leaving
highly proliferative OPCs scattered throughout the spinal cord in both gray and white
matter by E15 prior to expressing MBP shortly before birth198. This coincides
chronologically with the even distribution of MBP-positive cells in the WT spinal cord
explants, in which these ventrally-derived OPCs migrated normally in culture over the
course of five days (Figure 5.1). The second wave of dorsal oligodendrocyte production
accounts for just 20% of spinal cord OPCs, which lack the migratory and proliferative
capacity of OPCs associated with the ventral wave199. Differentiation into
oligodendrocytes expressing mature myelin proteins including MBP occurs in the ventral
and dorsal funiculi, marking the onset of active axon ensheathment. The rate of
differentiation and ensuing myelination increases postnatally for up to eight months,
peaking around one month205.
With respect to this physiological timeline of typical myelin development, the
Cyp11a1 KO explants do not appear to numerically hinder oligodendrocyte generation
by the E17.5 fixation point, as evidenced by the broadly distributed MBP-positive cells
characterizing both the WT and KO tissue (Figure 5.1). If anything, the MBP mean
fluorescence intensity quantification (Figure 5.3) suggests that the absence of
neurosteroid hormones in the KO explants leads to an overproduction of
oligodendrocytes. If this is in fact the case, excess oligodendrocytes might then fail to
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migrate radially from the ventral and dorsal funiculi, instead accumulating along the
midline of the spinal cord along the rostral/caudal axis.
The underlying reasons for this potential overproduction defect, not to mention its
functional consequences, are not clear from these experiments alone. Multiple factors in
isolation or in parallel could contribute to this unique phenotype, including, but not
limited to, insufficient space to accommodate all of the oligodendrocytes, diminished
migratory and/or proliferative cues, and indirect effects on overall spinal cord anatomy
that interfere with migration and/or proliferation. The notoriously high energetic demand
of oligodendrocytes and the myelin sheaths they form is yet another factor that would
almost certainly induce further perinatal cellular stress192. It is even conceivable that
reactive oxygen species and other toxic byproducts of the biological stress response
might play a role, along with the adrenal, hepatic, and pulmonary abnormalities
previously characterized, in the postnatal lethality of Cyp11a1 KO pups.
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CHAPTER 6: Concluding Remarks

6.1 Summary of conclusions
With our continually evolving understanding of the molecular mechanisms
underpinning demyelinating diseases like MS, increasing evidence for crosstalk
between the CNS and the endocrine system cannot be discounted. The highly
reproducible impact of neurosteroid hormones including P4 on remyelination begs the
question of their role(s) in early myelin development. The work described here provides
novel insights into the intricacies of CNS-derived P4 signaling, along with potential
kinetic and regulatory functions in sustaining normal oligodendrocyte development in
the embryonic spinal cord. An increased emphasis on the influence of neuroendocrine
factors on myelin development, maintenance, and regeneration in pathological contexts
will undoubtedly hold myriad implications for oligodendroglial biology and improved
treatments for demyelinating disorders.
In Chapter 3, the cerebellar slice culture system was implemented in P7 WT
mice to interrogate the effects of P4 on developmental myelination. In accordance with
the current literature concerning neurosteroid-induced remyelination, culturing the
cerebellar slices in 20 µM Nes, a synthetic P4 derivative, resulted in a significant
increase in expression of the mature myelin protein MBP. However, contrary to what
has been published with regards to the molecular mechanisms responsible for P4driven myelin repair, the elevated MBP expression in the cerebellar slices is not solely
attributable to the classical nPR. Repeating the cerebellar slice experiments with Nes
treatment in a PRKO mouse strain in which the KO has no functional nPR revealed
expedited myelination in the KO animals after one week in culture. This advanced
myelin maturation was evidenced by greater quantities of myelinated fibers at the
expense of individual oligodendrocytes lacking processes making physical contact with
axons. The accelerated myelination effect due to Nes was therefore magnified in the
absence of nPR, indicating involvement of other P4 receptor candidates, of which 11
have been identified.
The existence of numerous P4 receptors is the first major caveat I encountered
to studying neurosteroid hormones like P4 in isolation. Since all 11 P4 receptors are
expressed, albeit at varying levels, in oligodendrocytes in all stages of maturation, I
would have needed to probe each individual receptor in order to delineate those
participating in developmental myelination. The extremely short half-life of P4 must also
be considered, given its propensity to introduce the possibility of confounding P4 activity
with that of its metabolites, namely ALLO. Multiple receptors and rapid metabolism,
coupled with the fact that CNS-resident cells, primarily astrocytes, serve as endogenous
sources of P4, deterred me from pursuing the PRKO mouse model further. Alternatively,
I sought to continue studying developmental myelination in a completely steroid-free
environment to eliminate the any neurosteroid hormone interference in the data.
In Chapter 4, the establishment of a transgenic mouse colony lacking the
CYP11A1 gene encoding the p450scc enzyme enabled me to prevent all endogenous
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steroid production in the KO genotype. This enzyme is responsible for the initial
conversion of cholesterol to Preg, the immediate precursor to P4 and the first step in all
neurosteroid hormone synthesis. Notably, the CNS had never been evaluated in the
Cyp11a1 KO mouse prior to these studies. To this end, a thorough histological analysis
was performed in E18.5 embryos in an effort to characterize all phenotypes associated
with steroid hormone deprivation, with a focus on oligodendrocyte development.
Although neither embryo nor placenta weight was predictive of genotype, the majority of
the KO animals did not have visible optic discs as the WT animals did. H&E chemical
staining, on the other hand, not only provided confirmation of the previously described
adrenal defects in steroid-deprived tissue, but revealed novel phenotypes in the liver
and lung as well. The disorganization and rampant cellular degeneration in the adrenal
gland, decreased cellular vacuolation in the liver, and failed bronchial expansion in the
lungs all likely ensure the perinatal lethality seen in Cyp11a1 KO mice. These adrenal,
hepatic, and pulmonary abnormalities inhibit proper secretion of regulatory hormones,
cellular metabolism, and respiration, respectively.
In stark contrast to the glaring peripheral abnormalities, no major differences in
CNS anatomy were observed among the WT, Het, and KO genotypes. Paraffinembedded brain sections were subject to H&E staining for basic structure, cresyl violet
and TUJ1 staining for neural anatomy, and cleaved caspase-3 for cell death patterns.
Transverse spinal cord sections were also subject to H&E and TUJ1 staining. Perhaps
more surprising than the normal CNS anatomy in the Cyp11a1 KO mice was the
seemingly normal distribution of oligodendrocytes as assessed by Olig2 and MBP IHC.
Despite these unremarkable histological findings, I still suspected the Cyp11a1of KO
mice might suffer functional repercussions of steroid hormone-starved
oligodendrocytes.
In Chapter 5, the cerebellar slice method was replaced with a spinal cord explant
procedure due to postnatal lethality in Cyp11a1 KO mice. Spinal cords were dissected
from E12.5 embryos, cultured in specially formulated steroid-free media until
physiological E17.5, and fixed and fluorescently labeled with antibodies to the
oligodendrocyte transcription factor Nkx2.2 and the mature myelin protein MBP. WT,
Het, and KO spinal cord tissue featured broadly distributed Nkx2.2- and MBP-positive
cells. In addition to this diffuse expression, a brightly labeled bundle of MBP-positive
cells ran along the midline of each KO explant. Fluorescence intensity measurements
alone did not fully encompass the scope of the phenotype at hand; I therefore
collaborated with the Bio-Imaging Resource Center to generate line plots of Nkx2.2 and
MBP fluorescence intensities across the length of the explants. The algorithm-based
line plot representations convey dramatic peaks of MBP positivity found along the
midlines of KO spinal cord tissue. Further experiments are warranted to determine if this
robust phenotype is related to oligodendrocyte overproduction and/or migratory or
proliferative errors.

68

6.2 Implications for oligodendroglial development
The complex process of developmental myelination entails constant crosstalk
among glial cells and the surrounding extracellular environment. OPCs, by necessity
due to their ventricular origin, migrate rapidly and extensively, often through dense
tissue, to populate the CNS206. Successful myelination requires a carefully orchestrated
collaboration of long-range guidance cues, mediators of cellular motility, and factors that
inhibit further migration once OPCs reach their final destinations. Semaphorin and netrin
proteins are the most thoroughly studied long-range OPC guidance cues that facilitate
ventral to dorsal migration. Potent chemorepellents include netrin-1, some semaphorins,
Bmp4, Bmp7, Tgfß1, and Reelin, while CNTF in concert with several other semaphorins
acts as strong chemoattractants207. OPCs are simultaneously under the influence of an
array of ECM proteins. Laminin, fibronectin, and vitronectin encourage, whereas
collagen prevents, migration, and tenascin-C is thought to regulate migration speed by
interfering with OPC motility208. Recently conducted live imaging of OPC migration in
developing brain slices brings to light the notion that the vasculature serves as a
substrate for OPC migration. Expansive interactions between migrating OPCs and
blood vessels are observed, with the former moving in crawling and jumping motions
along the latter. Wnt-mediated OPC-blood vessel contact in turn stimulates migration at
the expense of differentiation209. Wnt in parallel with chemokines CXCL1 and CXCL12
enables the cessation of migration to trigger differentiation when appropriate.
Byproducts of the cholesterol biosynthetic pathway such as isoprenoids play pivotal
roles in this transition phase. The spinal cord MBP phenotype I have identified in mice
unable to metabolize cholesterol may therefore result from dysregulated migration cues
that leave MBP-positive cells susceptible to premature differentiation prior to the
completion of migration. Cholesterol itself, presumably produced in normal quantities in
the Cyp11a1 KO mouse, is sufficient to activate myelin gene expression, which would
account for the MBP positivity in OPCs with migratory defects210.
Yet another possible explanation for the seemingly paradoxical phenotype of
increased MBP fluorescence intensity in the Cyp11a1 KO spinal cord explants is an
overproduction of OPCs. Ventrally- and dorsally-derived OPCs comprise two distinct
migratory waves in the spinal cord. Under physiological conditions, these waves
generate an excess of OPCs with access to limited survival factors, not to mention
space211. This tendency towards overproduction is not restricted to the spinal cord. In
the developing optic nerve, nearly half of all oligodendrocytes die as a direct result of
competition for survival signals such as platelet-derived growth factor (PDGF) and
insulin-like growth factor (IGF). Adding PDGF to the developing optic nerve in culture
has been shown to drastically decrease OPC and oligodendrocyte death by 90%212.
Abnormally high PDGF and/or IGF levels in the Cyp11a1 KO spinal cord explants may
contribute to the observed MBP phenotype. The optic nerve findings described above
indicate that while OPC overproduction is the norm, unanimous OPC survival is not.
Performing cleaved-caspase 3 staining on the Cyp11a1 WT and KO spinal cord as was
done in the brain could expose any differences in cell death frequency.

69

In addition to molecular survival factors, OPCs rely heavily on astrocytes and
axons for sustenance. Premyelinating oligodendrocytes respond primarily to astrocytederived signals until day three post-differentiation, at which point axonal signals are the
dominant mediators of oligodendrocyte fate. One such axonal signal, neuregulin (NRG),
may be responsible for the coupling of myelinating oligodendrocyte number to total
axonal surface area213. According to this model, PDGF receptors are immediately
eliminated from newly differentiated oligodendrocytes. Without sensitivity to former
survival factors like PDGF, the oligodendrocytes must reach an axon in need of
myelination within a matter of days to avoid death214. A mutually beneficial relationship
is born in which bare axons need oligodendrocytes for myelination and the
oligodendrocytes depend on axonal cues for survival. This elegant example of biological
synergy ensures neuronal and oligodendroglial preservation without imposing
superfluous energy demands due to a chronic overabundance of OPCs. Maintaining the
Cyp11a1 spinal cords a few days longer in culture could prove very informative in terms
of neurosteroid effects on axon-glia communication. The endurance of the MBP
phenotype over time might imply an important role for neurosteroids in matching
oligodendrocyte quantity to axonal need.
6.3 Implications for demyelinating diseases
As the primary lipid component of myelin, cholesterol is a critical component in
both developmental and pathological contexts. The spinal cord explant experiments
provide confirmation that the mere presence of cholesterol is not sufficient for proper
myelination. On a similar note, abnormal cholesterol synthesis and recycling have been
repeatedly observed in the MS CNS215. Demyelination essentially leads to an
accumulation of myelin debris, largely comprised of cholesterol, in the brain and spinal
cord. Neurodegenerative diseases often compromise the BBB, allowing this cholesterol
debris from damaged myelin to cross into the periphery. Ensuing low cholesterol levels
in the CNS present further obstacles to remyelination, especially on oligodendrocytes to
maximize Preg and P4 production, respectively. The extracellular environment of acute
lesions is much more amenable to cholesterol metabolism than that of chronic lesions,
the latter of which teem with foamy phagocytes that have lost their lipid recycling
capabilities216. Significant cholesterol and subsequent neurosteroid loss from the CNS
therefore partially account for the steady decrease in spontaneous remyelination seen
as MS progresses and cholesterol synthesis becomes more and more restricted. This
notion is supported by the finding that dietary supplementation of cholesterol to
chronically ill MS patients stimulates the production of growth factors linked to
oligodendrocyte proliferation and differentiation requisite to remyelination217. On the
contrary, inhibiting cholesterol synthesis either pharmacologically or genetically as in the
Cyp11a1 mouse, undermines myelin repair in animal models of cuprizone-induced
demyelination218.
Despite the clear need for continuous cholesterol processing in remyelination,
several compounds that directly inhibit enzymes relevant to the cholesterol synthesis
pathway actually promote OPC differentiation. The widely agreed upon assumption is
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that steroid precursors known as sterols are responsible for this perplexing effect,
mirroring the apparent neuroprotective capacity of P4 intermediates like ALLO. Multiple
pro-myelinating small molecules identified in high throughput chemical screens mediate
myelin formation by inhibition of enzymes within the cholesterol biosynthesis pathway,
as opposed to signaling through their canonical receptors. The subsequent aggregation
of 8,9-unsaturated sterols has been shown to promote OPC differentiation into mature
oligodendrocytes219. The presence of these sterols, if sufficient to induce OPC
differentiation, might partially account for the increased MBP expression in the PRKO
cerebellar slices and/or the spinal cord MBP phenotype in which placental neurosteroids
were no longer available. The ability to stimulate OPC differentiation into myelinating
oligodendrocytes through pharmacological modulation of CNS cholesterol synthesis
could introduce a new class of therapeutic targets for demyelinating diseases like MS.
The importance of generating new oligodendrocytes from pre-existing OPC stem cell
populations cannot be overstated. Studies in zebrafish suggest that oligodendrocytes
that survive demyelinating insults often direct new myelin formation to neuronal cell
bodies rather than axons, recapitulating a common pathological feature of MS. On the
contrary, oligodendrocytes generated from OPCs following demyelination produce
greater quantities of myelin properly targeted to damaged myelin sheaths204. Based on
this data, prompt and complete clearance of myelin debris along with expedited
production of new oligodendrocytes, perhaps via regulation of cholesterol synthesis,
should be prioritized in MS drug development efforts.
6.4 Future directions
The novel findings addressed here regarding the relevance of neurosteroid
synthesis to myelinogenesis lend themselves to ample future research opportunities.
The observation that P4 stimulates MBP expression in developing cerebellar slices
independently of nPR leaves the question of the molecular mechanism underpinning
this phenomenon unanswered. Ongoing efforts to characterize this mechanism might
hone in on each of the 11 P4 receptors using genetic and experimental techniques.
Ideally, a KO strain corresponding to each receptor would be generated, and cerebellar
slices from these strains evaluated for MBP expression. Subsequent RNA-Seq
experiments might shed light on the signaling pathways activated, either directly or
indirectly, by different P4 receptors. One possible rationale for the diminished
myelination seen in the PRKO Het as compared to the KO cerebellar slices is inhibition
of differentiation due to premature vascular detachment of OPCs. Abnormal Wnt
signaling, for example, can exert this effect, leading to clusters of OPCs adjacent to
blood vessels. Further exploration of the relationship of the OPC clusters to the
surrounding vasculature could help determine whether or not this is the case in the Nestreated Het PRKO cerebellar slices. Perhaps Nes signaling through an alternative P4
receptor in the absence of nPR modulates Wnt signaling in a manner that actually
enhances OPC differentiation. The complex interactions between P4, nascent OPCs,
and the vasculature is worthy of additional research, as MS lesions often feature OPCs
clustered around a central vein209. The quiescent OPCs then block additional OPC
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migration to the demyelinated portion of the axon while simultaneously compromising
the associated vessels220.
The surprising results of the PRKO experiments conducted here may initially
appear to contradict claims in the literature that P4 promotes remyelination through
nPR. However, it is my belief that the increased MBP expression and enhanced
myelination in the KO compared to the Het cerebellar slices simply emphasizes the
acute need to distinguish between myelinogenesis and remyelination. Investigations
into potential MS therapeutics have been largely predicated on the idea that
remyelination recapitulates developmental myelination despite growing evidence to the
contrary. Multiple factors including glial scarring, buildup of myelin and other cellular
debris, and chronic inflammation in cases of progressive MS likely serve as blockades
to the processes underlying myelinogenesis under physiological conditions early in life.
Parsing out the molecular differences in oligodendrocyte development versus
remyelination necessitated by injury or disease will prove critical to improving current
treatment modalities for MS and other related disorders. Defining the role(s) of
neurosteroid hormones, from synthesis to signaling, in myelin development versus
myelin regeneration is a pivotal component of this urgent endeavor.
The P4-specific impact on oligodendrocytes in development and disease is
merely one example of the broader neuroendocrine scope of myelin formation and
regeneration. The spinal cord explant MBP midline phenotype in Cyp11a1 KO mice
typifies the pertinence of cholesterol biosynthesis and metabolism within the CNS. One
time- and labor-intensive yet equally informative experiment would involve reintroducing
single neurosteroids one by one to the cultured explants to establish which hormones
are responsible for particular aspects of oligodendrocyte development during early
myelination. My prediction is one neurosteroid hormone in isolation would be
inadequate to entirely rescue the midline phenotype, simply given the wide-ranging
intricacies of the neurosteroid synthesis pathway from cholesterol.
Regardless of the hormones needed to reverse the spinal cord phenotype,
determining the source of the elevated oligodendroglial density along the midline of
explants devoid of neurosteroids remains a critical task. Future experiments
discriminating between proliferation, migration, and overproduction defects are needed
to advance the field’s limited understanding of oligodendrocyte maturation from NPCs.
One such experiment to assess the involvement of cell proliferation in the spinal cord
explant phenotype is to include staining with a marker such as BrdU or Ki67. Since
these stains are best suited for cell suspensions or monolayers, they might not fully
penetrate the thick spinal cord explants. Applying these stains to dissociated
oligodendrocyte cultures, though less physiologically relevant than intact spinal cord
tissue, could serve as a starting point. Even the dissociated cultures have their
drawbacks, namely the rapid loss of OPC-specific markers from differentiated
oligodendrocytes. Whereas BrdU incorporation among OPCs is therefore not
representative of their proliferation rate, the relative quantities of OPCs versus
oligodendrocytes are much more accurate proliferative indicators213. Simply staining for
Olig2 along with MBP to determine the absolute numbers of OPCs and
oligodendrocytes in the explants is therefore superior to BrdU or Ki67 markers as a
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method to establish a proliferation defect underlying the spinal cord phenotype. Followup experiments would ideally address the postnatal consequences of excessive
oligodendrocyte production. Presumably, the oligodendrocytes that seem to be stuck in
the midline of the spinal cord explants will fail to contact a bare axon and die within a
matter of days. Depending on how efficiently astrocytes and microglia can clear the
debris, the midline phenotype might in fact disappear by the time of birth. These
temporal aspects of oligodendrocyte development also raise the question of a similar
phenotype in the embryonic and/or early postnatal brain lacking neurosteroid hormones.
Abundantly clear endocrine involvement in neurodegenerative disease reiterates
the as of yet enigmatic sexual dimorphism corresponding with MS diagnosis and
severity. Differential hormone production accompanied by distinct molecular and cellular
responses to those hormones in males and females demands further investigation,
especially in women who have been historically underrepresented in biomedical
research. Clarifying the gender-specific roles of individual neurosteroid hormones
in
oligodendrocyte maturation during physiological and pathological conditions will impel
the field in the direction of personalized medicine. At the very minimum, the general
understanding of oligodendrocyte development and remyelination as uniform processes
is a vastly oversimplified one. The concept of sexual dimorphism as it pertains to both
basic and translational neurobiology must guide future efforts to pharmacologically
disrupt, and optimally prevent, MS progression in all of those afflicted.
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